Christopher Goetz

Title	Professor
Institution	Rush University, Rush Medical College
Department	Neurological Sciences
Address	Chicago IL 60612
vCard	Download vCard

Overview

overview

My Scopus ID is 36063561200.
My NIH COMMONS name is CGOETZ.

Bibliographic

selected publications

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.

Cardoso F, Goetz CG, Mestre TA, Sampaio C, Adler CH, Berg D, Bloem BR, Burn DJ, Fitts MS, Gasser T, Klein C, de Tijssen MAJ, Lang AE, Lim SY, Litvan I, Meissner WG, Mollenhauer B, Okubadejo N, Okun MS, Postuma RB, Svenningsson P, Tan LCS, Tsunemi T, Wahlstrom-Helgren S, Gershanik OS, Fung VSC, Trenkwalder C. A Statement of the MDS on Biological Definition, Staging, and Classification of Parkinson's Disease. Mov Disord. 2023 Dec 13. PMID: 38093469.

Citations:
Mestre TA, Luo S, Stebbins GT, Sampaio C, Goetz CG. Reply to: "The Framework for Diagnostic Criteria in Movement Disorders: The Value of Methodological Tools and Combined Criteria". Mov Disord. 2023 09; 38(9):1763-1764. PMID: 37718268.

Citations:
Cotton AC, Scorr L, McDonald W, Comella C, Perlmutter JS, Goetz CG, Jankovic J, Marsh L, Factor S, Jinnah HA. Assessing the Severity of Cervical Dystonia: Ask the Doctor or Ask the Patient? Mov Disord Clin Pract. 2023 Sep; 10(9):1399-1403. PMID: 37772296.

Citations:
Goetz CG, Zou H, Stebbins GT, Schrag A, Mestre TA, Luo S. Reply to: Comment on "Summing MDS-UPDRS Parts 1?+?2 (Non-motor and Motor Experience of Daily Living): The Patient's Voice". Mov Disord. 2023 08; 38(8):1564. PMID: 37565401.

Citations:
Mestre TA, Fabbri M, Luo S, Stebbins GT, Goetz CG, Sampaio C. A Unified Framework for Evidence-Based Diagnostic Criteria Programs in Movement Disorders. Mov Disord. 2023 07; 38(7):1156-1162. PMID: 37156735.

Citations:
Collerton D, Barnes J, Diederich NJ, Dudley R, Ffytche D, Friston K, Goetz CG, Goldman JG, Jardri R, Kulisevsky J, Lewis SJG, Nara S, O'Callaghan C, Onofrj M, Pagonabarraga J, Parr T, Shine JM, Stebbins G, Taylor JP, Tsuda I, Weil RS. Understanding visual hallucinations: A new synthesis. Neurosci Biobehav Rev. 2023 07; 150:105208. PMID: 37141962.

Citations:
Zou H, Goetz CG, Stebbins GT, Schrag A, Mestre TA, Luo S. Summing MDS-UPDRS Parts 1?+?2 (Non-motor and Motor Experience of Daily Living): The Patient's Voice. Mov Disord. 2023 07; 38(7):1363-1364. PMID: 37087725.

Citations:
Riechmann R, Jakubovski E, Essing J, Haas M, Goetz CG, Stebbins GT, M?ller-Vahl KR. The Rush Video-Based Tic Rating Scale-Revised: A Practice-Oriented Revision. Mov Disord Clin Pract. 2023 May; 10(5):802-810. PMID: 37205238.

Citations:
Chevalier G, Udovin L, Otero-Losada M, Bordet S, Capani F, Luo S, Goetz CG, Perez-Lloret S. Genetics of Neurogenic Orthostatic Hypotension in Parkinson's Disease, Results from a Cross-Sectional In Silico Study. Brain Sci. 2023 Mar 17; 13(3). PMID: 36979316.

Citations:
Hall DA, Voigt RM, Cantu-Jungles TM, Hamaker B, Engen PA, Shaikh M, Raeisi S, Green SJ, Naqib A, Forsyth CB, Chen T, Manfready R, Ouyang B, Rasmussen HE, Sedghi S, Goetz CG, Keshavarzian A. An open label, non-randomized study assessing a prebiotic fiber intervention in a small cohort of Parkinson's disease participants. Nat Commun. 2023 02 18; 14(1):926. PMID: 36801916.

Citations:
Kaasinen V, Luo S, Martinez-Martin P, Goetz CG, Stebbins GT. Cross-Cultural Differences in Patient Perceptions of Dyskinesia in Parkinson's Disease. Mov Disord. 2023 04; 38(4):688-692. PMID: 36670051.

Citations:
Guo Y, Goetz CG, Stebbins GT, Mestre TA, Luo S. Using Movement Disorder Society Unified Parkinson's Disease Rating Scale Parts 2 and 3 Simultaneously: Combining the Patient Voice with Clinician Ratings. Mov Disord. 2023 03; 38(3):453-463. PMID: 36621935.

Citations:
Goetz CG, Choi D, Guo Y, Stebbins GT, Mestre TA, Luo S. It Is as It Was: MDS-UPDRS Part III Scores Cannot Be Combined with Other Parts to Give a Valid Sum. Mov Disord. 2023 02; 38(2):342-347. PMID: 36480107.

Citations:
Gonz?lez DA, Tosin MHS, Goetz CG. The plight of loneliness in Parkinson's disease: New opportunities. Parkinsonism Relat Disord. 2022 Dec; 105:145-148. PMID: 36333238.

Citations:
Tosin MHS, de Oliveira BGRB, Goetz CG, Morisky D, McConvey V, Skorvanek M, Schrag A, Martinez-Martin P, Stebbins GT. Rating Scales for Medication Adherence in Parkinson's Disease: A Systematic Review for Critique and Recommendations. Mov Disord Clin Pract. 2023 Feb; 10(2):175-189. PMID: 36825050.

Citations:
Guo Y, Stebbins GT, Mestre TA, Goetz CG, Luo S. Movement Disorder Society Unified Parkinson's Disease Rating Scale Motor Examination Retains Its 2-Domain Profile in Both On and Off States. Mov Disord Clin Pract. 2022 Nov; 9(8):1149-1151. PMID: 36339308.

Citations:
Tosin MHS, Stebbins GT, Goetz CG, Hagerman RJ, Hessl D, Zolecki MA, Todd PK, Leehey MA, Hall DA. Fragile X-associated tremor ataxia syndrome rating scale: Revision and content validity using a mixed method approach. Front Neurol. 2022; 13:977380. PMID: 36188408.

Citations:
Manfready RA, Goetz CG, Keshavarzian A. Intestinal microbiota and neuroinflammation in Parkinson's disease: At the helm of the gut-brain axis. Int Rev Neurobiol. 2022; 167:81-99. PMID: 36427960.

Citations:
Luo S, Zou H, Stebbins GT, Schwarzschild MA, Macklin EA, Chan J, Oakes D, Simuni T, Goetz CG. Dissecting the Domains of Parkinson's Disease: Insights from Longitudinal Item Response Theory Modeling. Mov Disord. 2022 09; 37(9):1904-1914. PMID: 35841312.

Citations:
Afshari M, Hernandez AV, Nonnekes J, Bloem BR, Goetz CG. Are Virtual Objective Assessments of Fall-Risk Feasible and Safe for People with Parkinson's Disease? Mov Disord Clin Pract. 2022 Aug; 9(6):799-804. PMID: 35937474.

Citations:
Pal G, Mangone G, Ouyang B, Ehrlich D, Saunders-Pullman R, Bressman S, Alcalay RN, Marder K, Aasly J, Mouradian MM, Anderson S, Bernard B, Stebbins G, Sani S, Afshari M, Verhagen L, de Bie RMA, Foltynie T, Hall D, Corvol JC, Goetz CG. Reply to: Cognitive Effects of Deep Brain Stimulation in GBA-Related Parkinson's Disease. Ann Neurol. 2022 08; 92(2):345-346. PMID: 35687082.

Citations:
Luo S, Goetz CG, Choi D, Aggarwal S, Mestre TA, Stebbins GT. Resolving Missing Data from the Movement Disorder Society Unified Parkinson's Disease Rating Scale: Implications for Telemedicine. Mov Disord. 2022 08; 37(8):1749-1755. PMID: 35716143.

Citations:
Voigt RM, Wang Z, Brown JM, Engen PA, Naqib A, Goetz CG, Hall DA, Metman LV, Shaikh M, Forsyth CB, Keshavarzian A. Gut microbial metabolites in Parkinson's disease: Association with lifestyle, disease characteristics, and treatment status. Neurobiol Dis. 2022 08; 170:105780. PMID: 35654277.

Citations:
Manfready RA, Forsyth CB, Voigt RM, Hall DA, Goetz CG, Keshavarzian A. Gut-Brain Communication in Parkinson's Disease: Enteroendocrine Regulation by GLP-1. Curr Neurol Neurosci Rep. 2022 07; 22(7):335-342. PMID: 35633466.

Citations:
Tosin MHS, Goetz CG, Bispo DPCF, Ferraz HB, Leite MAA, Hall DA, Stebbins GT, Oliveira BGRB. Parkinson's Disease Medication Adherence Scale: Conceptualization, Scale Development, and Clinimetric Testing Plan. Front Aging Neurosci. 2022; 14:900029. PMID: 35645779.

Citations:
Goetz CG, Drouin E. Two faces of the teacher: Comparing editions of Charcot's Le?ons du mardi. J Hist Neurosci. 2022 Oct-Dec; 31(4):512-523. PMID: 35316148.

Citations:
Jagota P, Srivanitchapoom P, Petchrutchatachart S, Singmaneesakulchai S, Pisarnpong A, Lolekha P, Setthawatcharawanich S, Chairangsaris P, Limotai N, Mekawichai P, Panyakaew P, Phokaewvarangkul O, Sringean J, Pitakpatapee Y, LaPelle N, Martinez-Martin P, Ren X, Luo S, Stebbins GT, Goetz CG, Bhidayasiri R. Validation of the Thai Version of the Movement Disorder Society-Sponsored Revision of the Unified Parkinson's Disease Rating Scale. J Mov Disord. 2022 May; 15(2):151-155. PMID: 35287261.

Citations:
Di Luca DG, Kirby AE, Goetz CG. Implementation and Outcomes of a Movement Disorder Society-Sponsored Peer Reviewing Education and Mentoring Program. Mov Disord. 2022 05; 37(5):1093-1097. PMID: 35261103.

Citations:
Khalil H, Aldaajani ZF, Aldughmi M, Al-Sharman A, Mohammad T, Mehanna R, El-Jaafary SI, Dahshan A, Ben Djebara M, Kamel WA, Amer HA, Farghal M, Abdulla F, Al-Talai N, Snineh MA, Farhat N, Jamali FA, Matar RK, Abdelraheem HS, Ghonimi NAM, Al-Melh MA, Elbhrawy S, Alotaibi MS, Elaidy SA, Almuammar SA, Al-Hashel JY, Gouider R, Samir H, Mhiri C, Skorvanek M, Lin J, Martinez-Martin P, Stebbins GT, Luo S, Goetz CG, Bajwa JA. Validation of the Arabic Version of the Movement Disorder Society-Unified Parkinson's Disease Rating Scale. Mov Disord. 2022 04; 37(4):826-841. PMID: 35218056.

Citations:
Pal G, Mangone G, Hill EJ, Ouyang B, Liu Y, Lythe V, Ehrlich D, Saunders-Pullman R, Shanker V, Bressman S, Alcalay RN, Garcia P, Marder KS, Aasly J, Mouradian MM, Link S, Rosenbaum M, Anderson S, Bernard B, Wilson R, Stebbins G, Nichols WC, Welter ML, Sani S, Afshari M, Verhagen L, de Bie RMA, Foltynie T, Hall D, Corvol JC, Goetz CG. Parkinson Disease and Subthalamic Nucleus Deep Brain Stimulation: Cognitive Effects in GBA Mutation Carriers. Ann Neurol. 2022 03; 91(3):424-435. PMID: 34984729.

Citations:
Tosin MHS, de Oliveira BGRB, Goetz CG, Morisky D, McConvey V, Stebbins GT. Rating scales for medication adherence in people living with Parkinson's disease: a systematic review protocol. JBI Evid Synth. 2022 01 01; 20(1):260-269. PMID: 34446669.

Citations:
Schwarzschild MA, Ascherio A, Casaceli C, Curhan GC, Fitzgerald R, Kamp C, Lungu C, Macklin EA, Marek K, Mozaffarian D, Oakes D, Rudolph A, Shoulson I, Videnovic A, Scott B, Gauger L, Aldred J, Bixby M, Ciccarello J, Gunzler SA, Henchcliffe C, Brodsky M, Keith K, Hauser RA, Goetz C, LeDoux MS, Hinson V, Kumar R, Espay AJ, Jimenez-Shahed J, Hunter C, Christine C, Daley A, Leehey M, de Marcaida JA, Friedman JH, Hung A, Bwala G, Litvan I, Simon DK, Simuni T, Poon C, Schiess MC, Chou K, Park A, Bhatti D, Peterson C, Criswell SR, Rosenthal L, Durphy J, Shill HA, Mehta SH, Ahmed A, Deik AF, Fang JY, Stover N, Zhang L, Dewey RB, Gerald A, Boyd JT, Houston E, Suski V, Mosovsky S, Cloud L, Shah BB, Saint-Hilaire M, James R, Zauber SE, Reich S, Shprecher D, Pahwa R, Langhammer A, LaFaver K, LeWitt PA, Kaminski P, Goudreau J, Russell D, Houghton DJ, Laroche A, Thomas K, McGraw M, Mari Z, Serrano C, Blindauer K, Rabin M, Kurlan R, Morgan JC, Soileau M, Ainslie M, Bodis-Wollner I, Schneider RB, Waters C, Ratel AS, Beck CA, Bolger P, Callahan KF, Crotty GF, Klements D, Kostrzebski M, McMahon GM, Pothier L, Waikar SS, Lang A, Mestre T. Effect of Urate-Elevating Inosine on Early Parkinson Disease Progression: The SURE-PD3 Randomized Clinical Trial. JAMA. 2021 09 14; 326(10):926-939. PMID: 34519802.

Citations:
Olvera C, Stebbins GT, Goetz CG, Kompoliti K. TikTok Tics: A Pandemic Within a Pandemic. Mov Disord Clin Pract. 2021 Nov; 8(8):1200-1205. PMID: 34765687.

Citations:
Luo S, Zou H, Goetz CG, Choi D, Oakes D, Simuni T, Stebbins GT. Novel Approach to Movement Disorder Society-Unified Parkinson's Disease Rating Scale Monitoring in Clinical Trials: Longitudinal Item Response Theory Models. Mov Disord Clin Pract. 2021 Oct; 8(7):1083-1091. PMID: 34631944.

Citations:
Ren X, Lin J, Stebbins GT, Goetz CG, Luo S. Prognostic Modeling of Parkinson's Disease Progression Using Early Longitudinal Patterns of Change. Mov Disord. 2021 12; 36(12):2853-2861. PMID: 34327755.

Citations:
Kaasinen V, Scheperjans F, K?rpp? M, Korpela J, Br?ck A, Sipil? JOT, Joutsa J, J?rvel? J, Eerola-Rautio J, Martikainen MH, Airaksinen K, Stebbins GT, Martinez-Martin P, Goetz CG, Lin J, Luo S, Pekkonen E. Validation of the Finnish Version of the Unified Dyskinesia Rating Scale. Eur Neurol. 2021; 84(6):444-449. PMID: 34261060.

Citations:
Goetz CG, Stebbins GT. Is Telemedicine the New Normal or Is the Office Visit Still the Movement Disorder Option of Choice? Mov Disord. 2021 07; 36(7):1481-1482. PMID: 34018252.

Citations:
Saper CB, Klein C, McArthur JC, Pearl PL, Goetz CG. Remembrance of Things Past: A Critical Step in Changing our Future. Ann Neurol. 2021 10; 90(4):521-523. PMID: 34173267.

Citations:
Manfready RA, Engen PA, Verhagen Metman L, Sanzo G, Goetz CG, Hall DA, Forsyth CB, Raeisi S, Voigt RM, Keshavarzian A. Attenuated Postprandial GLP-1 Response in Parkinson's Disease. Front Neurosci. 2021; 15:660942. PMID: 34276285.

Citations:
Cisneros E, Vu JP, Lee HY, Chen Q, Benadof CN, Zhang Z, Pettitt EA, Joshi SK, Barbano RL, Jankovic J, Jinnah HA, Perlmutter JS, Berman BD, Mahajan A, Goetz CG, Stebbins GT, Comella CL, Peterson DA. Does Raising the Arms Modify Head Tremor Severity in Cervical Dystonia? Tremor Other Hyperkinet Mov (N Y). 2021 06 23; 11:21. PMID: 34221696.

Citations:
Goetz CG. Will Artificial Intelligence Outperform the Clinical Neurologist in the Near Future? No. Mov Disord Clin Pract. 2021 May; 8(4):529-531. PMID: 33981786.

Citations:
Siuda J, Boczarska-Jedynak M, Budrewicz S, Dulski J, Figura M, Fiszer U, Gajos A, Gorzkowska A, Koziorowska-Gawron E, Koziorowski D, Krygowska-Wajs A, Rudzinska-Bar M, Slawek J, Tos M, W?jcik-Pedziwiatr M, Lin J, Luo S, Martinez-Martin P, Stebbins GT, Goetz CG, Opala G. Validation of the Polish version of the Unified Dyskinesia Rating Scale (UDysRS). Neurol Neurochir Pol. 2021; 55(2):186-194. PMID: 33528833.

Citations:
Vu JP, Lee HY, Chen Q, Cisneros E, Barbano RL, Goetz CG, Jankovic J, Jinnah HA, Perlmutter JS, Berman BD, Appelbaum MI, Stebbins GT, Comella CL, Peterson DA. Head tremor and pain in cervical dystonia. J Neurol. 2021 May; 268(5):1945-1950. PMID: 33417005.

Citations:
Bloem BR, Trenkwalder C, Sanchez-Ferro A, Kalia LV, Alcalay R, Chiang HL, Kang UJ, Goetz C, Brundin P, Papa SM. COVID-19 Vaccination for Persons with Parkinson's Disease: Light at the End of the Tunnel? J Parkinsons Dis. 2021; 11(1):3-8. PMID: 33523021.

Citations:
Fuller RLM, S?nchez-Ferro ?, Goetz CG, Martinez-Martin P, Stebbins GT. In Support of Electronic Versions of Movement Disorder Society Rating Scales. Mov Disord. 2021 01; 36(1):270-271. PMID: 33492790.

Citations:
Cisneros E, Stebbins GT, Chen Q, Vu JP, Benadof CN, Zhang Z, Barbano RL, Fox SH, Goetz CG, Jankovic J, Jinnah HA, Perlmutter JS, Adler CH, Factor SA, Reich SG, Rodriguez R, Severt LL, Stover NP, Berman BD, Comella CL, Peterson DA. It's tricky: Rating alleviating maneuvers in cervical dystonia. J Neurol Sci. 2020 Dec 15; 419:117205. PMID: 33160248.

Citations:
Friedman JH, Goetz CG. Apathy in Parkinson disease: Why we should care. Neurology. 2020 11 17; 95(20):893-894. PMID: 33004607.

Citations:
Mogenot M, Hein-Halbgewachs L, Goetz C, Ouamara N, Droz-Desprez D, Strazielle C, Albecker S, Mengus B, Strub M, Mani?re MC, Richardin P, Wang S, Piga G, Dalstein A, Anastasio D. Efficacy, tolerability, and safety of an innovative medical device for improving oral accessibility during oral examination in special-needs patients: A multicentric clinical trial. PLoS One. 2020; 15(9):e0239898. PMID: 32986784.

Citations:
Siuda J, Boczarska-Jedynak M, Budrewicz S, Dulski J, Figura M, Fiszer U, Gajos A, Gorzkowska A, Koziorowska-Gawron E, Koziorowski D, Krygowska-Wajs A, Rudzinska-Bar M, Slawek J, Ren X, Luo S, Martinez-Martin P, Stebbins G, Goetz CG, Opala G. Validation of the Polish version of the Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS). Neurol Neurochir Pol. 2020; 54(5):416-425. PMID: 32639019.

Citations:
Tosin MHS, Stebbins GT, Goetz CG, Santana RF, Leite MAA, Oliveira BGRB. Measuring Medication Adherence in Parkinson's Disease: A Systematic Review of Contributing Components in Rating Scales. Mov Disord Clin Pract. 2020 Aug; 7(6):607-615. PMID: 32775505.

Citations:
Faust-Socher A, Anis S, Kestenbaum M, Shabtai H, Taichman T, Bar David A, Ezra A, Peretz C, Rosenberg A, Brozgol M, Herman T, Stebbins GT, Goetz CG, Mart?nez-Mart?n P, Luo ST, Ren X, Giladi N, Gurevich T. Validation of the Hebrew Version of the Unified Dyskinesia Rating Scale. Neuroepidemiology. 2020; 54(4):356-362. PMID: 32541146.

Citations:
Diederich NJ, Uchihara T, Grillner S, Goetz CG. The Evolution-Driven Signature of Parkinson's Disease. Trends Neurosci. 2020 07; 43(7):475-492. PMID: 32499047.

Citations:
Tosin MHS, Goetz CG, Luo S, Choi D, Stebbins GT. Item Response Theory Analysis of the MDS-UPDRS Motor Examination: Tremor vs. Nontremor Items. Mov Disord. 2020 09; 35(9):1587-1595. PMID: 32469456.

Citations:
Goetz CG, Stebbins GT, Luo S. Movement Disorder Society-Unified Parkinson's Disease Rating Scale Use in the Covid-19 Era. Mov Disord. 2020 06; 35(6):911. PMID: 32320498.

Citations:
Paixao T, DiFranco MD, Ljuhar R, Ljuhar D, Goetz C, Bertalan Z, Dimai HP, Nehrer S. A novel quantitative metric for joint space width: data from the Osteoarthritis Initiative (OAI). Osteoarthritis Cartilage. 2020 08; 28(8):1055-1061. PMID: 32335143.

Citations:
Rotonda C, Soudant M, Epstein J, Goetz C, Jankowski R, Guillemin F. Optimizing DyNaChron instrument for assessing chronic nasal dysfunction symptoms by Rasch analysis. Rhinology. 2020 Apr 01; 58(2):158-165. PMID: 31886475.

Citations:
Hill EJ, Goetz CG, Stebbins GT, Hagerman R, Ouyang B, Hall DA. Placebo Response in Fragile X-associated Tremor/Ataxia Syndrome. Mov Disord Clin Pract. 2020 Apr; 7(3):298-302. PMID: 32258228.

Citations:
Bernard BA, Carns D, Stebbins GT, Goldman JG, Goetz CG. Relationship of Movement Disorders Society-Unified Parkinson's Disease Rating Scale Nonmotor Symptoms to Cognitive Functioning in Patients with Parkinson's Disease. Mov Disord Clin Pract. 2020 Apr; 7(3):279-283. PMID: 32258225.

Citations:
Chen Q, Vu JP, Cisneros E, Benadof CN, Zhang Z, Barbano RL, Goetz CG, Jankovic J, Jinnah HA, Perlmutter JS, Appelbaum MI, Stebbins GT, Comella CL, Peterson DA. Postural Directionality and Head Tremor in Cervical Dystonia. Tremor Other Hyperkinet Mov (N Y). 2020; 10. PMID: 32015932.

Citations:
Piot I, Schweyer K, Respondek G, Stamelou M, Sckopke P, Schenk T, Goetz CG, Stebbins GT, H?glinger GU. The Progressive Supranuclear Palsy Clinical Deficits Scale. Mov Disord. 2020 04; 35(4):650-661. PMID: 31951049.

Citations:
Witek NP, Goetz CG, Stebbins GT. Preface. Int Rev Neurobiol. 2020; 153:xi-xii. PMID: 32563295.

Citations:
Schwarzschild MA, Macklin EA, Bakshi R, Battacharyya S, Logan R, Espay AJ, Hung AY, Bwala G, Goetz CG, Russell DS, Goudreau JL, Parashos SA, Saint-Hilaire MH, Rudolph A, Hare JM, Curhan GC, Ascherio A. Sex differences by design and outcome in the Safety of Urate Elevation in PD (SURE-PD) trial. Neurology. 2019 10 01; 93(14):e1328-e1338. PMID: 31484712.

Citations:
Ren X, Lin J, Luo S, Goetz CG, Stebbins GT, Cubo E. Successful use of the Unified Dyskinesia Rating Scale regardless of PD- or dyskinesia-duration. Parkinsonism Relat Disord. 2019 10; 67:113-116. PMID: 31495732.

Citations:
Evans AH, Okai D, Weintraub D, Lim SY, O'Sullivan SS, Voon V, Krack P, Sampaio C, Post B, Leentjens AFG, Martinez-Martin P, Stebbins GT, Goetz CG, Schrag A. Scales to assess impulsive and compulsive behaviors in Parkinson's disease: Critique and recommendations. Mov Disord. 2019 06; 34(6):791-798. PMID: 31136681.

Citations:
Vizcarra JA, S?nchez-Ferro ?, Maetzler W, Marsili L, Zavala L, Lang AE, Martinez-Martin P, Mestre TA, Reilmann R, Hausdorff JM, Dorsey ER, Paul SS, Dexheimer JW, Wissel BD, Fuller RLM, Bonato P, Tan AH, Bloem BR, Kopil C, Daeschler M, Bataille L, Kleiner G, Cedarbaum JM, Klucken J, Merola A, Goetz CG, Stebbins GT, Espay AJ. The Parkinson's disease e-diary: Developing a clinical and research tool for the digital age. Mov Disord. 2019 05; 34(5):676-681. PMID: 30901492.

Citations:
Goetz CG. Developing Skills That Serve Our Journal, Your Colleagues as Potential Authors, and You. Mov Disord Clin Pract. 2019 Mar; 6(3):200-201. PMID: 30949550.

Citations:
Diederich NJ, James Surmeier D, Uchihara T, Grillner S, Goetz CG. Parkinson's disease: Is it a consequence of human brain evolution? Mov Disord. 2019 04; 34(4):453-459. PMID: 30759321.

Citations:
Hall DA, Stebbins GT, Jacquemont S, Berry-Kravis E, Goetz CG, Hagerman R, Zhang L, Leehey MA. Clinimetric Properties of the Fragile X-associated Tremor Ataxia Syndrome Rating Scale. Mov Disord Clin Pract. 2019 Feb; 6(2):120-124. PMID: 30838310.

Citations:
Hanson RE, Truesdell M, Stebbins GT, Weathers AL, Goetz CG. Telemedicine vs Office Visits in a Movement Disorders Clinic: Comparative Satisfaction of Physicians and Patients. Mov Disord Clin Pract. 2019 Jan; 6(1):65-69. PMID: 30746418.

Citations:
Pavy-Le Traon A, Cotterill N, Amarenco G, Duerr S, Kaufmann H, Lahrmann H, Tison F, Wenning GK, Goetz CG, Poewe W, Sampaio C, Schrag A, Rascol O, Martinez-Martin P, Stebbins GT. Clinical Rating Scales for Urinary Symptoms in Parkinson Disease: Critique and Recommendations. Mov Disord Clin Pract. 2018 Sep-Oct; 5(5):479-491. PMID: 30515437.

Citations:
Postuma RB, Poewe W, Litvan I, Lewis S, Lang AE, Halliday G, Goetz CG, Chan P, Slow E, Seppi K, Schaffer E, Rios-Romenets S, Mi T, Maetzler C, Li Y, Heim B, Bledsoe IO, Berg D. Validation of the MDS clinical diagnostic criteria for Parkinson's disease. Mov Disord. 2018 10; 33(10):1601-1608. PMID: 30145797.

Citations:
Berg D, Adler CH, Bloem BR, Chan P, Gasser T, Goetz CG, Halliday G, Lang AE, Lewis S, Li Y, Liepelt-Scarfone I, Litvan I, Marek K, Maetzler C, Mi T, Obeso J, Oertel W, Olanow CW, Poewe W, Rios-Romenets S, Sch?ffer E, Seppi K, Heim B, Slow E, Stern M, Bledsoe IO, Deuschl G, Postuma RB. Movement disorder society criteria for clinically established early Parkinson's disease. Mov Disord. 2018 10; 33(10):1643-1646. PMID: 30145841.

Citations:
Luo S, Ren X, Han W, Goetz CG, Stebbins GT. Missing Data in the Unified Dysksinesia Rating Scale (UDysRS). Mov Disord Clin Pract. 2018 Sep-Oct; 5(5):523-526. PMID: 30515442.

Citations:
Witek N, Stebbins GT, Goetz CG. What influences placebo and nocebo responses in Parkinson's disease? Mov Disord. 2018 08; 33(8):1204-1212. PMID: 30132980.

Citations:
Skorvanek M, Martinez-Martin P, Stebbins GT, Goetz CG. Reply: Hoehn and Yahr stage 3 and Postural stability item in the Movement Disorder Society-Unified Parkinson's Disease Rating Scale. Mov Disord. 2018 07; 33(7):1189-1190. PMID: 30153386.

Citations:
Mestre TA, Busse M, Davis AM, Quinn L, Rodrigues FB, Burgunder JM, Carlozzi NE, Walker F, Ho AK, Sampaio C, Goetz CG, Cubo E, Martinez-Martin P, Stebbins GT. Rating Scales and Performance-based Measures for Assessment of Functional Ability in Huntington's Disease: Critique and Recommendations. Mov Disord Clin Pract. 2018 Jul-Aug; 5(4):361-372. PMID: 30363510.

Citations:
Lhuillier L, Ghetemme C, Boich? M, Yahia R, Houmad N, Zaidi M, Goetz C, Perone JM. Visibility and Depth of the Stromal Demarcation Line After Corneal Collagen Cross-Linking Using Anterior Segment Optical Coherence Tomography: Comparison Between Isoosmolar and Hypoosmolar Riboflavin. Cornea. 2018 May; 37(5):567-573. PMID: 29300266.

Citations:
Skorvanek M, Martinez-Martin P, Kovacs N, Zezula I, Rodriguez-Violante M, Corvol JC, Taba P, Seppi K, Levin O, Schrag A, Aviles-Olmos I, Alvarez-Sanchez M, Arakaki T, Aschermann Z, Benchetrit E, Benoit C, Bergareche-Yarza A, Cervantes-Arriaga A, Chade A, Cormier F, Datieva V, Gallagher DA, Garretto N, Gdovinova Z, Gershanik O, Grofik M, Han V, Kadastik-Eerme L, Kurtis MM, Mangone G, Martinez-Castrillo JC, Mendoza-Rodriguez A, Minar M, Moore HP, Muldmaa M, Mueller C, Pinter B, Poewe W, Rallmann K, Reiter E, Rodriguez-Blazquez C, Singer C, Valkovic P, Goetz CG, Stebbins GT. Relationship between the MDS-UPDRS and Quality of Life: A large multicenter study of 3206 patients. Parkinsonism Relat Disord. 2018 07; 52:83-89. PMID: 29625875.

Citations:
Mestre TA, Carlozzi NE, Ho AK, Burgunder JM, Walker F, Davis AM, Busse M, Quinn L, Rodrigues FB, Sampaio C, Goetz CG, Cubo E, Martinez-Martin P, Stebbins GT. Quality of Life in Huntington's Disease: Critique and Recommendations for Measures Assessing Patient Health-Related Quality of Life and Caregiver Quality of Life. Mov Disord. 2018 05; 33(5):742-749. PMID: 29570848.

Citations:
Hassan A, Dorsey ER, Goetz CG, Bloem BR, Guttman M, Tanner CM, Mari Z, Pantelyat A, Galifianakis NB, Bajwa JA, Gatto EM, Cubo E. Telemedicine Use for Movement Disorders: A Global Survey. Telemed J E Health. 2018 12; 24(12):979-992. PMID: 29565764.

Citations:
Skorvanek M, Goldman JG, Jahanshahi M, Marras C, Rektorova I, Schmand B, van Duijn E, Goetz CG, Weintraub D, Stebbins GT, Martinez-Martin P. Reply: MoCA for cognitive screening in Parkinson's disease: Beware of floor effect. Mov Disord. 2018 03; 33(3):499-500. PMID: 29460975.

Citations:
Martinez-Martin P, Skorvanek M, Rojo-Abuin JM, Gregova Z, Stebbins GT, Goetz CG. Validation study of the hoehn and yahr scale included in the MDS-UPDRS. Mov Disord. 2018 04; 33(4):651-652. PMID: 29322548.

Citations:
Mestre TA, Forjaz MJ, Mahlknecht P, Cardoso F, Ferreira JJ, Reilmann R, Sampaio C, Goetz CG, Cubo E, Martinez-Martin P, Stebbins GT. Rating Scales for Motor Symptoms and Signs in Huntington's Disease: Critique and Recommendations. Mov Disord Clin Pract. 2018 Mar-Apr; 5(2):111-117. PMID: 30363393.

Citations:
Mestre TA, Bachoud-L?vi AC, Marinus J, Stout JC, Paulsen JS, Como P, Duff K, Sampaio C, Goetz CG, Cubo E, Stebbins GT, Martinez-Martin P. Rating scales for cognition in Huntington's disease: Critique and recommendations. Mov Disord. 2018 02; 33(2):187-195. PMID: 29278291.

Citations:
Skorvanek M, Goldman JG, Jahanshahi M, Marras C, Rektorova I, Schmand B, van Duijn E, Goetz CG, Weintraub D, Stebbins GT, Martinez-Martin P. Global scales for cognitive screening in Parkinson's disease: Critique and recommendations. Mov Disord. 2018 02; 33(2):208-218. PMID: 29168899.

Citations:
Akbostanci MC, Bayram E, Yilmaz V, Rzayev S, ?zkan S, Tokcaer AB, Saka E, Durmaz Celik FN, Barut B?, T?fekcioglu Z, Acarer A, Balaban H, Erer S, Dogu O, Kibaroglu S, Aydin N, Hanagasi H, Elibol B, Emre M, Stebbins GT, Goetz CG. Turkish Standardization of Movement Disorders Society Unified Parkinson's Disease Rating Scale and Unified Dyskinesia Rating Scale. Mov Disord Clin Pract. 2018 Jan-Feb; 5(1):54-59. PMID: 30363359.

Citations:
Neiter E, Goetz C, Tortuyaux F, Ehrhardt A, Houmad N, Perone JM. [Practical assessment of DSAEK in the management of endothelial decompensation following penetrating keratoplasty]. J Fr Ophtalmol. 2017 Dec; 40(10):844-852. PMID: 29132691.

Citations:
Goetz CG. Closing the celebration of 200 years of Parkinson's Essay on the Shaking Palsy: Where do we go in the next 200 years? Mov Disord. 2017 12; 32(12):1651-1652. PMID: 29119602.

Citations:
Vittal P, Pulliam CL, Goetz CG, Ouyang B, Jankovic J, Ramirez-Castaneda JL, Heldman DA. Does Added Objective Tremor Monitoring Improve Clinical Outcomes in Essential Tremor Treatment? Mov Disord Clin Pract. 2018 Jan-Feb; 5(1):96-98. PMID: 30746399.

Citations:
Zitser J, Peretz C, Ber David A, Shabtai H, Ezra A, Kestenbaum M, Brozgol M, Rosenberg A, Herman T, Balash Y, Gadoth A, Thaler A, Stebbins GT, Goetz CG, Tilley BC, Luo ST, Liu Y, Giladi N, Gurevich T. Validation of the Hebrew version of the Movement Disorder Society-Unified Parkinson's Disease Rating Scale. Parkinsonism Relat Disord. 2017 Dec; 45:7-12. PMID: 28965872.

Citations:
Obeso JA, Stamelou M, Goetz CG, Poewe W, Lang AE, Weintraub D, Burn D, Halliday GM, Bezard E, Przedborski S, Lehericy S, Brooks DJ, Rothwell JC, Hallett M, DeLong MR, Marras C, Tanner CM, Ross GW, Langston JW, Klein C, Bonifati V, Jankovic J, Lozano AM, Deuschl G, Bergman H, Tolosa E, Rodriguez-Violante M, Fahn S, Postuma RB, Berg D, Marek K, Standaert DG, Surmeier DJ, Olanow CW, Kordower JH, Calabresi P, Schapira AHV, Stoessl AJ. Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy. Mov Disord. 2017 Sep; 32(9):1264-1310. PMID: 28887905.

Citations:
Goetz CG, Stebbins GT, Chung KA, Nicholas AP, Hauser RA, Merkitch D, Stacy MA. Topiramate as an adjunct to amantadine in the treatment of dyskinesia in parkinson's disease: A randomized, double-blind, placebo-controlled multicenter study. Mov Disord. 2017 09; 32(9):1335-1336. PMID: 28646494.

Citations:
Luo S, Liu Y, Teresi JA, Stebbins GT, Goetz CG. Differential item functioning in the Unified Dyskinesia Rating Scale (UDysRS). Mov Disord. 2017 Aug; 32(8):1244-1249. PMID: 28568607.

Citations:
Goetz CG. Rev Neurol (Paris). 2017 Dec; 173(10):628-636. PMID: 28501142.

Citations:
Skorvanek M, Martinez-Martin P, Kovacs N, Rodriguez-Violante M, Corvol JC, Taba P, Seppi K, Levin O, Schrag A, Foltynie T, Alvarez-Sanchez M, Arakaki T, Aschermann Z, Aviles-Olmos I, Benchetrit E, Benoit C, Bergareche-Yarza A, Cervantes-Arriaga A, Chade A, Cormier F, Datieva V, Gallagher DA, Garretto N, Gdovinova Z, Gershanik O, Grofik M, Han V, Huang J, Kadastik-Eerme L, Kurtis MM, Mangone G, Martinez-Castrillo JC, Mendoza-Rodriguez A, Minar M, Moore HP, Muldmaa M, Mueller C, Pinter B, Poewe W, Rallmann K, Reiter E, Rodriguez-Blazquez C, Singer C, Tilley BC, Valkovic P, Goetz CG, Stebbins GT. Differences in MDS-UPDRS Scores Based on Hoehn and Yahr Stage and Disease Duration. Mov Disord Clin Pract. 2017 Jul-Aug; 4(4):536-544. PMID: 30363418.

Citations:
Mestre TA, van Duijn E, Davis AM, Bachoud-L?vi AC, Busse M, Anderson KE, Sampaio C, Goetz CG, Cubo E, Stebbins GT, Martinez-Martin P. Response to letter by Saenz-Farret et al. on "Rating scales for behavioral symptoms in Huntington's disease: Critique and recommendations". Mov Disord. 2017 03; 32(3):482. PMID: 28256103.

Citations:
Martino D, Pringsheim TM, Cavanna AE, Colosimo C, Hartmann A, Leckman JF, Luo S, Munchau A, Goetz CG, Stebbins GT, Martinez-Martin P. Systematic review of severity scales and screening instruments for tics: Critique and recommendations. Mov Disord. 2017 03; 32(3):467-473. PMID: 28071825.

Citations:
Kordower JH, Goetz CG, Chu Y, Halliday GM, Nicholson DA, Musial TF, Marmion DJ, Stoessl AJ, Sossi V, Freeman TB, Olanow CW. Robust graft survival and normalized dopaminergic innervation do not obligate recovery in a Parkinson disease patient. Ann Neurol. 2017 Jan; 81(1):46-57. PMID: 27900791.

Citations:
Pal GD, Ouyang B, Serrano G, Shill HA, Goetz C, Stebbins G, Metman LV, Driver-Dunckley E, Mehta SH, Caviness JN, Sabbagh MN, Adler CH, Beach TG. Comparison of neuropathology in Parkinson's disease subjects with and without deep brain stimulation. Mov Disord. 2017 02; 32(2):274-277. PMID: 27911008.

Citations:
Bernard BA, Metman LV, Levine L, Ouyang B, Leurgans S, Goetz CG. Sildenafil in the Treatment of Erectile Dysfunction in Parkinson's Disease. Mov Disord Clin Pract. 2017 May-Jun; 4(3):412-415. PMID: 30363412.

Citations:
Goetz CG, Liu Y, Stebbins GT, Wang L, Tilley BC, Teresi JA, Merkitch D, Luo S. Gender-, age-, and race/ethnicity-based differential item functioning analysis of the movement disorder society-sponsored revision of the Unified Parkinson's disease rating scale. Mov Disord. 2016 12; 31(12):1865-1873. PMID: 27943473.

Citations:
Mestre TA, van Duijn E, Davis AM, Bachoud-L?vi AC, Busse M, Anderson KE, Ferreira JJ, Mahlknecht P, Tumas V, Sampaio C, Goetz CG, Cubo E, Stebbins GT, Martinez-Martin P. Rating scales for behavioral symptoms in Huntington's disease: Critique and recommendations. Mov Disord. 2016 10; 31(10):1466-1478. PMID: 27296904.

Citations:
Shulman LM, Armstrong M, Ellis T, Gruber-Baldini A, Horak F, Nieuwboer A, Parashos S, Post B, Rogers M, Siderowf A, Goetz CG, Schrag A, Stebbins GT, Martinez-Martin P. Disability Rating Scales in Parkinson's Disease: Critique and Recommendations. Mov Disord. 2016 10; 31(10):1455-1465. PMID: 27193358.

Citations:
Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, Marek K, Litvan I, Lang AE, Halliday G, Goetz CG, Gasser T, Dubois B, Chan P, Bloem BR, Adler CH, Deuschl G. Abolishing the 1-year rule: How much evidence will be enough? Mov Disord. 2016 11; 31(11):1623-1627. PMID: 27666574.

Citations:
Perez-Lloret S, Ciampi de Andrade D, Lyons KE, Rodr?guez-Bl?zquez C, Chaudhuri KR, Deuschl G, Cruccu G, Sampaio C, Goetz CG, Schrag A, Martinez-Martin P, Stebbins G. Rating Scales for Pain in Parkinson's Disease: Critique and Recommendations. Mov Disord Clin Pract. 2016 Nov-Dec; 3(6):527-537. PMID: 30363588.

Citations:
Tison F, Keywood C, Wakefield M, Durif F, Corvol JC, Eggert K, Lew M, Isaacson S, Bezard E, Poli SM, Goetz CG, Trenkwalder C, Rascol O. A Phase 2A Trial of the Novel mGluR5-Negative Allosteric Modulator Dipraglurant for Levodopa-Induced Dyskinesia in Parkinson's Disease. Mov Disord. 2016 09; 31(9):1373-80. PMID: 27214664.

Citations:
Postuma RB, Berg D, Adler CH, Bloem BR, Chan P, Deuschl G, Gasser T, Goetz CG, Halliday G, Joseph L, Lang AE, Liepelt-Scarfone I, Litvan I, Marek K, Oertel W, Olanow CW, Poewe W, Stern M. The new definition and diagnostic criteria of Parkinson's disease. Lancet Neurol. 2016 05; 15(6):546-8. PMID: 27302120.

Citations:
Yu RL, Wu RM, Chan AY, Mok V, Wu YR, Tilley BC, Luo S, Wang L, LaPelle NR, Stebbins GT, Goetz CG. Cross-Cultural Differences of the Non-Motor Symptoms Studied by the Traditional Chinese Version of the International Parkinson and Movement Disorder Society- Unified Parkinson's Disease Rating Scale. Mov Disord Clin Pract. 2017 Jan-Feb; 4(1):68-77. PMID: 28345011.

Citations:
Comella CL, Perlmutter JS, Jinnah HA, Waliczek TA, Rosen AR, Galpern WR, Adler CA, Barbano RL, Factor SA, Goetz CG, Jankovic J, Reich SG, Rodriguez RL, Severt WL, Zurowski M, Fox SH, Stebbins GT. Clinimetric testing of the comprehensive cervical dystonia rating scale. Mov Disord. 2016 Apr; 31(4):563-9. PMID: 26971359.

Citations:
Bloem BR, Marinus J, Almeida Q, Dibble L, Nieuwboer A, Post B, Ruzicka E, Goetz C, Stebbins G, Martinez-Martin P, Schrag A. Measurement instruments to assess posture, gait, and balance in Parkinson's disease: Critique and recommendations. Mov Disord. 2016 09; 31(9):1342-55. PMID: 26945525.

Citations:
Kluger BM, Herlofson K, Chou KL, Lou JS, Goetz CG, Lang AE, Weintraub D, Friedman J. Parkinson's disease-related fatigue: A case definition and recommendations for clinical research. Mov Disord. 2016 05; 31(5):625-31. PMID: 26879133.

Citations:
Pal GD, Hall D, Ouyang B, Phelps J, Alcalay R, Pauciulo MW, Nichols WC, Clark L, Mejia-Santana H, Blasucci L, Goetz CG, Comella C, Colcher A, Gan-Or Z, Rouleau GA, Marder K. Genetic and Clinical Predictors of Deep Brain Stimulation in Young-Onset Parkinson's Disease. Mov Disord Clin Pract. 2016 Sep-Oct; 3(5):465-471. PMID: 27709117.

Citations:
Friedman JH, Beck JC, Chou KL, Clark G, Fagundes CP, Goetz CG, Herlofson K, Kluger B, Krupp LB, Lang AE, Lou JS, Marsh L, Newbould A, Weintraub D. Fatigue in Parkinson's disease: report from a mutidisciplinary symposium. NPJ Parkinsons Dis. 2016; 2. PMID: 27239558.

Citations:
Goetz CG. Charcot, hysteria, and simulated disorders. Handb Clin Neurol. 2016; 139:11-23. PMID: 27719832.

Citations:
Diederich NJ, Goldman JG, Stebbins GT, Goetz CG. Failing as doorman and disc jockey at the same time: Amygdalar dysfunction in Parkinson's disease. Mov Disord. 2016 Jan; 31(1):11-22. PMID: 26650182.

Citations:
Berg D, Postuma RB, Adler CH, Bloem BR, Chan P, Dubois B, Gasser T, Goetz CG, Halliday G, Joseph L, Lang AE, Liepelt-Scarfone I, Litvan I, Marek K, Obeso J, Oertel W, Olanow CW, Poewe W, Stern M, Deuschl G. MDS research criteria for prodromal Parkinson's disease. Mov Disord. 2015 Oct; 30(12):1600-11. PMID: 26474317.

Citations:
Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, Obeso J, Marek K, Litvan I, Lang AE, Halliday G, Goetz CG, Gasser T, Dubois B, Chan P, Bloem BR, Adler CH, Deuschl G. MDS clinical diagnostic criteria for Parkinson's disease. Mov Disord. 2015 Oct; 30(12):1591-601. PMID: 26474316.

Citations:
Poewe W, Goetz CG. Preface. Mov Disord. 2015 Sep 15; 30(11):1441. PMID: 26301896.

Citations:
Pal GD, Persinger V, Bernard B, Ouyang B, Goetz CG, Verhagen Metman L. The Core Assessment Program for Surgical Interventional Therapies in Parkinson's Disease (CAPSIT-PD): Tolerability of Preoperative Neuropsychological Testing for Deep Brain Stimulation in Parkinson's Disease. Mov Disord Clin Pract. 2015 Dec; 2(4):379-383. PMID: 30363547.

Citations:
Guillemin F, Rat AC, Goetz C, Spitz E, Pouchot J, Coste J. The Mini-OAKHQOL for knee and hip osteoarthritis quality of life was obtained following recent shortening guidelines. J Clin Epidemiol. 2016 Jan; 69:70-8. PMID: 26111768.

Citations:
Warren Olanow C, Bartus RT, Baumann TL, Factor S, Boulis N, Stacy M, Turner DA, Marks W, Larson P, Starr PA, Jankovic J, Simpson R, Watts R, Guthrie B, Poston K, Henderson JM, Stern M, Baltuch G, Goetz CG, Herzog C, Kordower JH, Alterman R, Lozano AM, Lang AE. Gene delivery of neurturin to putamen and substantia nigra in Parkinson disease: A double-blind, randomized, controlled trial. Ann Neurol. 2015 Aug; 78(2):248-57. PMID: 26061140.

Citations:
Hall DA, Forjaz MJ, Golbe LI, Litvan I, Payan CAM, Goetz CG, Leentjens AFG, Martinez-Martin P, Traon AP, Sampaio C, Post B, Stebbins G, Weintraub D, Schrag A. Scales to Assess Clinical Features of Progressive Supranuclear Palsy: MDS Task Force Report. Mov Disord Clin Pract. 2015 Jun; 2(2):127-134. PMID: 30363842.

Citations:
Suchorska B, Kunz M, Schniepp R, Jahn K, Goetz C, Tonn JC, Peraud A. Optimized surgical treatment for normal pressure hydrocephalus: comparison between gravitational and differential pressure valves. Acta Neurochir (Wien). 2015 Apr; 157(4):703-9. PMID: 25666108.

Citations:
Goetz CG, Luo S, Wang L, Tilley BC, LaPelle NR, Stebbins GT. Handling missing values in the MDS-UPDRS. Mov Disord. 2015 Oct; 30(12):1632-8. PMID: 25649812.

Citations:
Goetz CG, Pal G. Initial management of Parkinson's disease. BMJ. 2014 Dec 19; 349:g6258. PMID: 25527341.

Citations:
Goldman JG, Holden S, Ouyang B, Bernard B, Goetz CG, Stebbins GT. Diagnosing PD-MCI by MDS Task Force criteria: how many and which neuropsychological tests? Mov Disord. 2015 Mar; 30(3):402-6. PMID: 25449653.

Citations:
Kashihara K, Kondo T, Mizuno Y, Kikuchi S, Kuno S, Hasegawa K, Hattori N, Mochizuki H, Mori H, Murata M, Nomoto M, Takahashi R, Takeda A, Tsuboi Y, Ugawa Y, Yamanmoto M, Yokochi F, Yoshii F, Stebbins GT, Tilley BC, Luo S, Wang L, LaPelle NR, Goetz CG. Official Japanese Version of the Movement Disorder Society-Unified Parkinson's Disease Rating Scale: validation against the original English version. Mov Disord Clin Pract. 2014 Sep 01; 1(3):200-212. PMID: 25328906.

Citations:
Goldman JG, Stebbins GT, Leung V, Tilley BC, Goetz CG. Relationships among cognitive impairment, sleep, and fatigue in Parkinson's disease using the MDS-UPDRS. Parkinsonism Relat Disord. 2014 Nov; 20(11):1135-9. PMID: 25150770.

Citations:
Cubo E, Goetz CG, Stebbins GT, LaPelle NR, Tilley BC, Wang L, Luo S. Independent Spanish Validation of the Unified Dyskinesia Rating Scale. Mov Disord Clin Pract. 2014 Sep; 1(3):213-218. PMID: 27891530.

Citations:
Goetz CG, Bergen DC. Maynard M. Cohen, MD, PhD (1920-2014). Neurology. 2014 Jun 03; 82(22):1944-5. PMID: 25013889.

Citations:
Goetz CG, Vittal P, Maldonado J. How Do I Test for Postural Stability? Mov Disord Clin Pract. 2014 Jun; 1(2):144. PMID: 30868091.

Citations:
Achey M, Aldred JL, Aljehani N, Bloem BR, Biglan KM, Chan P, Cubo E, Dorsey ER, Goetz CG, Guttman M, Hassan A, Khandhar SM, Mari Z, Spindler M, Tanner CM, van den Haak P, Walker R, Wilkinson JR. The past, present, and future of telemedicine for Parkinson's disease. Mov Disord. 2014 Jun; 29(7):871-83. PMID: 24838316.

Citations:
Goetz CG, Stebbins GT, Wang L, LaPelle NR, Luo S, Tilley BC. IPMDS-Sponsored Scale Translation Program: Process, Format, and Clinimetric Testing Plan for the MDS-UPDRS and UDysRS. Mov Disord Clin Pract. 2014 Jun; 1(2):97-101. PMID: 27747259.

Citations:
Barton BR, Bernard B, Czernecki V, Goldman JG, Stebbins G, Dubois B, Goetz CG. Comparison of the Movement Disorder Society Parkinson's disease dementia criteria with neuropsychological testing. Mov Disord. 2014 Sep; 29(10):1252-7. PMID: 24821679.

Citations:
Diederich NJ, Stebbins G, Schiltz C, Goetz CG. Are patients with Parkinson's disease blind to blindsight? Brain. 2014 Jun; 137(Pt 6):1838-49. PMID: 24764573.

Citations:
Berg D, Postuma RB, Bloem B, Chan P, Dubois B, Gasser T, Goetz CG, Halliday GM, Hardy J, Lang AE, Litvan I, Marek K, Obeso J, Oertel W, Olanow CW, Poewe W, Stern M, Deuschl G. Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson's disease. Mov Disord. 2014 Apr; 29(4):454-62. PMID: 24619848.

Citations:
Tanner CM, Meng CC, Ravina B, Lang A, Kurlan R, Marek K, Oakes D, Seibyl J, Flagg E, Gauger L, Guest DD, Goetz CG, Kieburtz K, DiEuliis D, Fahn S, Elliott RA, Shoulson I. A practical approach to remote longitudinal follow-up of Parkinson's disease: the FOUND study. Mov Disord. 2014 May; 29(6):743-9. PMID: 24515275.

Citations:
Schwarzschild MA, Ascherio A, Beal MF, Cudkowicz ME, Curhan GC, Hare JM, Hooper DC, Kieburtz KD, Macklin EA, Oakes D, Rudolph A, Shoulson I, Tennis MK, Espay AJ, Gartner M, Hung A, Bwala G, Lenehan R, Encarnacion E, Ainslie M, Castillo R, Togasaki D, Barles G, Friedman JH, Niles L, Carter JH, Murray M, Goetz CG, Jaglin J, Ahmed A, Russell DS, Cotto C, Goudreau JL, Russell D, Parashos SA, Ede P, Saint-Hilaire MH, Thomas CA, James R, Stacy MA, Johnson J, Gauger L, Antonelle de Marcaida J, Thurlow S, Isaacson SH, Carvajal L, Rao J, Cook M, Hope-Porche C, McClurg L, Grasso DL, Logan R, Orme C, Ross T, Brocht AF, Constantinescu R, Sharma S, Venuto C, Weber J, Eaton K. Inosine to increase serum and cerebrospinal fluid urate in Parkinson disease: a randomized clinical trial. JAMA Neurol. 2014 Feb; 71(2):141-50. PMID: 24366103.

Citations:
Goldman JG, Stebbins GT, Dinh V, Bernard B, Merkitch D, deToledo-Morrell L, Goetz CG. Visuoperceptive region atrophy independent of cognitive status in patients with Parkinson's disease with hallucinations. Brain. 2014 Mar; 137(Pt 3):849-59. PMID: 24480486.

Citations:
Mart?nez-Mart?n P, Rodr?guez-Bl?zquez C, Forjaz MJ, Alvarez-S?nchez M, Arakaki T, Bergareche-Yarza A, Chade A, Garretto N, Gershanik O, Kurtis MM, Mart?nez-Castrillo JC, Mendoza-Rodr?guez A, Moore HP, Rodr?guez-Violante M, Singer C, Tilley BC, Huang J, Stebbins GT, Goetz CG. Relationship between the MDS-UPDRS domains and the health-related quality of life of Parkinson's disease patients. Eur J Neurol. 2014 Mar; 21(3):519-24. PMID: 24447695.

Citations:
Tilley BC, LaPelle NR, Goetz CG, Stebbins GT. Using cognitive pretesting in scale development for Parkinson's disease: the Movement Disorder Society Unified Parkinson's Disease Rating Scale (MDS-UPDRS) example. J Parkinsons Dis. 2014; 4(3):395-404. PMID: 24613868.

Citations:
Pedroso JL, Barsottini OG, Goetz CG. Babinski's contributions to cerebellar symptomatology: building the basis of the neurological examination. Arq Neuropsiquiatr. 2013 Dec; 71(12):973-5. PMID: 24347019.

Citations:
Goldman JG, Holden S, Bernard B, Ouyang B, Goetz CG, Stebbins GT. Defining optimal cutoff scores for cognitive impairment using Movement Disorder Society Task Force criteria for mild cognitive impairment in Parkinson's disease. Mov Disord. 2013 Dec; 28(14):1972-9. PMID: 24123267.

Citations:
Lang AE, Eberly S, Goetz CG, Stebbins G, Oakes D, Marek K, Ravina B, Tanner CM, Shoulson I. Movement disorder society unified Parkinson disease rating scale experiences in daily living: longitudinal changes and correlation with other assessments. Mov Disord. 2013 Dec; 28(14):1980-6. PMID: 24123383.

Citations:
Pulliam CL, Eichenseer SR, Goetz CG, Waln O, Hunter CB, Jankovic J, Vaillancourt DE, Giuffrida JP, Heldman DA. Continuous in-home monitoring of essential tremor. Parkinsonism Relat Disord. 2014 Jan; 20(1):37-40. PMID: 24126021.

Citations:
Elble R, Bain P, Forjaz MJ, Haubenberger D, Testa C, Goetz CG, Leentjens AF, Martinez-Martin P, Pavy-Le Traon A, Post B, Sampaio C, Stebbins GT, Weintraub D, Schrag A. Task force report: scales for screening and evaluating tremor: critique and recommendations. Mov Disord. 2013 Nov; 28(13):1793-800. PMID: 24038576.

Citations:
Dodel R, J?nsson B, Reese JP, Winter Y, Martinez-Martin P, Holloway R, Sampaio C, Ru?icka E, Hawthorne G, Oertel W, Poewe W, Stebbins G, Rascol O, Goetz CG, Schrag A. Measurement of costs and scales for outcome evaluation in health economic studies of Parkinson's disease. Mov Disord. 2014 Feb; 29(2):169-76. PMID: 23861335.

Citations:
Goetz CG, Vaughan CL, Goldman JG, Stebbins GT. I finally see what you see: Parkinson's disease visual hallucinations captured with functional neuroimaging. Mov Disord. 2014 Jan; 29(1):115-7. PMID: 23843193.

Citations:
Rodriguez-Blazquez C, Rojo-Abuin JM, Alvarez-Sanchez M, Arakaki T, Bergareche-Yarza A, Chade A, Garretto N, Gershanik O, Kurtis MM, Martinez-Castrillo JC, Mendoza-Rodriguez A, Moore HP, Rodriguez-Violante M, Singer C, Tilley BC, Huang J, Stebbins GT, Goetz CG, Martinez-Martin P. The MDS-UPDRS Part II (motor experiences of daily living) resulted useful for assessment of disability in Parkinson's disease. Parkinsonism Relat Disord. 2013 Oct; 19(10):889-93. PMID: 23791519.

Citations:
Albanese A, Sorbo FD, Comella C, Jinnah HA, Mink JW, Post B, Vidailhet M, Volkmann J, Warner TT, Leentjens AF, Martinez-Martin P, Stebbins GT, Goetz CG, Schrag A. Dystonia rating scales: critique and recommendations. Mov Disord. 2013 Jun 15; 28(7):874-83. PMID: 23893443.

Citations:
Pal G, Goetz CG. Assessing bradykinesia in parkinsonian disorders. Front Neurol. 2013; 4:54. PMID: 23760683.

Citations:
Goldman JG, Ghode RA, Ouyang B, Bernard B, Goetz CG, Stebbins GT. Dissociations among daytime sleepiness, nighttime sleep, and cognitive status in Parkinson's disease. Parkinsonism Relat Disord. 2013 Sep; 19(9):806-11. PMID: 23735187.

Citations:
Prodoehl J, Li H, Planetta PJ, Goetz CG, Shannon KM, Tangonan R, Comella CL, Simuni T, Zhou XJ, Leurgans S, Corcos DM, Vaillancourt DE. Diffusion tensor imaging of Parkinson's disease, atypical parkinsonism, and essential tremor. Mov Disord. 2013 Nov; 28(13):1816-22. PMID: 23674400.

Citations:
Goetz CG, Harter DH. Treating melancholia at home: theoretical wisdom and grim reality in the career of E.C. Seguin. Neurology. 2013 Apr 30; 80(18):1710-4. PMID: 23628930.

Citations:
Martinez-Martin P, Chaudhuri KR, Rojo-Abuin JM, Rodriguez-Blazquez C, Alvarez-Sanchez M, Arakaki T, Bergareche-Yarza A, Chade A, Garretto N, Gershanik O, Kurtis MM, Martinez-Castrillo JC, Mendoza-Rodriguez A, Moore HP, Rodriguez-Violante M, Singer C, Tilley BC, Huang J, Stebbins GT, Goetz CG. Assessing the non-motor symptoms of Parkinson's disease: MDS-UPDRS and NMS Scale. Eur J Neurol. 2015 Jan; 22(1):37-43. PMID: 23607783.

Citations:
Goetz CG. The Parkinson's disease multidisciplinary package. Mov Disord. 2013 May; 28(5):565. PMID: 23483614.

Citations:
Neely KA, Planetta PJ, Prodoehl J, Corcos DM, Comella CL, Goetz CG, Shannon KL, Vaillancourt DE. Force control deficits in individuals with Parkinson's disease, multiple systems atrophy, and progressive supranuclear palsy. PLoS One. 2013; 8(3):e58403. PMID: 23505500.

Citations:
Stebbins GT, Goetz CG, Burn DJ, Jankovic J, Khoo TK, Tilley BC. How to identify tremor dominant and postural instability/gait difficulty groups with the movement disorder society unified Parkinson's disease rating scale: comparison with the unified Parkinson's disease rating scale. Mov Disord. 2013 May; 28(5):668-70. PMID: 23408503.

Citations:
Goetz CG, Stebbins GT, Chung KA, Hauser RA, Miyasaki JM, Nicholas AP, Poewe W, Seppi K, Rascol O, Stacy MA, Nutt JG, Tanner CM, Urkowitz A, Jaglin JA, Ge S. Which dyskinesia scale best detects treatment response? Mov Disord. 2013 Mar; 28(3):341-6. PMID: 23390076.

Citations:
Goetz CG, Stebbins GT, Tilley BC. Calibration of unified Parkinson's disease rating scale scores to Movement Disorder Society-unified Parkinson's disease rating scale scores. Mov Disord. 2012 Sep 01; 27(10):1239-42. PMID: 22886777.

Citations:
Martinez-Martin P, Rodriguez-Blazquez C, Alvarez-Sanchez M, Arakaki T, Bergareche-Yarza A, Chade A, Garretto N, Gershanik O, Kurtis MM, Martinez-Castrillo JC, Mendoza-Rodriguez A, Moore HP, Rodriguez-Violante M, Singer C, Tilley BC, Huang J, Stebbins GT, Goetz CG. Expanded and independent validation of the Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS). J Neurol. 2013 Jan; 260(1):228-36. PMID: 22865238.

Citations:
Goldman JG, Weis H, Stebbins G, Bernard B, Goetz CG. Clinical differences among mild cognitive impairment subtypes in Parkinson's disease. Mov Disord. 2012 Aug; 27(9):1129-36. PMID: 22778009.

Citations:
Galpern WR, Corrigan-Curay J, Lang AE, Kahn J, Tagle D, Barker RA, Freeman TB, Goetz CG, Kieburtz K, Kim SY, Piantadosi S, Comstock Rick A, Federoff HJ. Sham neurosurgical procedures in clinical trials for neurodegenerative diseases: scientific and ethical considerations. Lancet Neurol. 2012 Jul; 11(7):643-50. PMID: 22710757.

Citations:
Antonini A, Abbruzzese G, Ferini-Strambi L, Tilley B, Huang J, Stebbins GT, Goetz CG, Barone P, Bandettini di Poggio M, Fabbrini G, Di Stasio F, Tinazzi M, Bovi T, Ramat S, Meoni S, Pezzoli G, Canesi M, Martinelli P, Maria Scaglione CL, Rossi A, Tambasco N, Santangelo G, Picillo M, Morgante L, Morgante F, Quatrale R, Sensi M, Pilleri M, Biundo R, Nordera G, Caria A, Pacchetti C, Zangaglia R, Lopiano L, Zibetti M, Zappia M, Nicoletti A, Quattrone A, Salsone M, Cossu G, Murgia D, Albanese A, Del Sorbo F. Validation of the Italian version of the Movement Disorder Society--Unified Parkinson's Disease Rating Scale. Neurol Sci. 2013 May; 34(5):683-7. PMID: 22678179.

Citations:
Corcos DM, Comella CL, Goetz CG. Tai chi for patients with Parkinson's disease. N Engl J Med. 2012 05 03; 366(18):1737-8; author reply 1738. PMID: 22551137.

Citations:
Goldman JG, Stebbins GT, Bernard B, Stoub TR, Goetz CG, deToledo-Morrell L. Entorhinal cortex atrophy differentiates Parkinson's disease patients with and without dementia. Mov Disord. 2012 May; 27(6):727-34. PMID: 22410753.

Citations:
Kapur SS, Stebbins GT, Goetz CG. Vibration therapy for Parkinson's disease: Charcot's studies revisited. J Parkinsons Dis. 2012; 2(1):23-7. PMID: 23939405.

Citations:
Barton B, Grabli D, Bernard B, Czernecki V, Goldman JG, Stebbins G, Dubois B, Goetz CG. Clinical validation of Movement Disorder Society-recommended diagnostic criteria for Parkinson's disease with dementia. Mov Disord. 2012 Feb; 27(2):248-53. PMID: 22162144.

Citations:
Goetz CG, Tilley BC, Stebbins GT. Dopamine dysregulation syndrome item from the MDS-UPDRS. Mov Disord. 2012 Jan; 27(1):166. PMID: 22025291.

Citations:
Seidel SE, Tilley BC, Huang P, Palesch YY, Bergmann KJ, Goetz CG, Swearingen CJ. Subject-investigator reproducibility of the Unified Parkinson's Disease Rating Scale. Parkinsonism Relat Disord. 2012 Mar; 18(3):230-3. PMID: 22018910.

Citations:
Fox SH, Katzenschlager R, Lim SY, Ravina B, Seppi K, Coelho M, Poewe W, Rascol O, Goetz CG, Sampaio C. The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's disease. Mov Disord. 2011 Oct; 26 Suppl 3:S2-41. PMID: 22021173.

Citations:
Seppi K, Weintraub D, Coelho M, Perez-Lloret S, Fox SH, Katzenschlager R, Hametner EM, Poewe W, Rascol O, Goetz CG, Sampaio C. The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor symptoms of Parkinson's disease. Mov Disord. 2011 Oct; 26 Suppl 3:S42-80. PMID: 22021174.

Citations:
Goetz CG, Stebbins GT, Theeuwes A, Stocchi F, Ferreira JJ, van de Witte S, Bronzova J. Temporal stability of the Unified Dyskinesia Rating Scale. Mov Disord. 2011 Dec; 26(14):2556-9. PMID: 21915907.

Citations:
Gallagher DA, Goetz CG, Stebbins G, Lees AJ, Schrag A. Validation of the MDS-UPDRS Part I for nonmotor symptoms in Parkinson's disease. Mov Disord. 2012 Jan; 27(1):79-83. PMID: 21915909.

Citations:
Goetz CG. The history of Parkinson's disease: early clinical descriptions and neurological therapies. Cold Spring Harb Perspect Med. 2011 Sep; 1(1):a008862. PMID: 22229124.

Citations:
Antonini A, Martinez-Martin P, Chaudhuri RK, Merello M, Hauser R, Katzenschlager R, Odin P, Stacy M, Stocchi F, Poewe W, Rascol O, Sampaio C, Schrag A, Stebbins GT, Goetz CG. Wearing-off scales in Parkinson's disease: critique and recommendations. Mov Disord. 2011 Oct; 26(12):2169-75. PMID: 21780180.

Citations:
Goetz CG, Stebbins GT, Ouyang B. Visual plus nonvisual hallucinations in Parkinson's disease: development and evolution over 10 years. Mov Disord. 2011 Oct; 26(12):2196-200. PMID: 21755536.

Citations:
Martinez-Martin P, Jeukens-Visser M, Lyons KE, Rodriguez-Blazquez C, Selai C, Siderowf A, Welsh M, Poewe W, Rascol O, Sampaio C, Stebbins GT, Goetz CG, Schrag A. Health-related quality-of-life scales in Parkinson's disease: critique and recommendations. Mov Disord. 2011 Nov; 26(13):2371-80. PMID: 21735480.

Citations:
Goldman JG, Vaughan CL, Goetz CG. An update expert opinion on management and research strategies in Parkinson's disease psychosis. Expert Opin Pharmacother. 2011 Sep; 12(13):2009-24. PMID: 21635198.

Citations:
Pavy-Le Traon A, Amarenco G, Duerr S, Kaufmann H, Lahrmann H, Shaftman SR, Tison F, Wenning GK, Goetz CG, Poewe W, Sampaio C, Schrag A, Stebbins GT, Rascol O. The Movement Disorders task force review of dysautonomia rating scales in Parkinson's disease with regard to symptoms of orthostatic hypotension. Mov Disord. 2011 Sep; 26(11):1985-92. PMID: 21547951.

Citations:
Goetz CG, McGhiey A. The movement disorder society and movement disorders: a modern history. Mov Disord. 2011 May; 26(6):939-46. PMID: 21626540.

Citations:
Meissner WG, Frasier M, Gasser T, Goetz CG, Lozano A, Piccini P, Obeso JA, Rascol O, Schapira A, Voon V, Weiner DM, Tison F, Bezard E. Priorities in Parkinson's disease research. Nat Rev Drug Discov. 2011 May; 10(5):377-93. PMID: 21532567.

Citations:
Goldman JG, Marr D, Zhou L, Ouyang B, Leurgans SE, Berry-Kravis E, Goetz CG. Racial differences may influence the role of cholecystokinin polymorphisms in Parkinson's disease hallucinations. Mov Disord. 2011 Aug 01; 26(9):1781-2. PMID: 21506165.

Citations:
H?gl B, Arnulf I, Comella C, Ferreira J, Iranzo A, Tilley B, Trenkwalder C, Poewe W, Rascol O, Sampaio C, Stebbins GT, Schrag A, Goetz CG. Scales to assess sleep impairment in Parkinson's disease: critique and recommendations. Mov Disord. 2010 Dec 15; 25(16):2704-16. PMID: 20931631.

Citations:
Goetz CG, Ouyang B, Negron A, Stebbins GT. Hallucinations and sleep disorders in PD: ten-year prospective longitudinal study. Neurology. 2010 Nov 16; 75(20):1773-9. PMID: 20962287.

Citations:
Schwid SR, Bausch J, Oakes D, Schuchter L, Tanner C, Forrest M, Lang AE, Shoulson I, Shoulson I, Hyson C, Oakes D, Flagg E, Rudolph A, Kieburtz K, Lang A, Fahn S, Gauger L, Goetz C. Cancer incidence in a trial of an antiapoptotic agent for Parkinson's disease. Mov Disord. 2010 Sep 15; 25(12):1801-8. PMID: 20669311.

Citations:
Forsaa EB, Larsen JP, Wentzel-Larsen T, Goetz CG, Stebbins GT, Aarsland D, Alves G. A 12-year population-based study of psychosis in Parkinson disease. Arch Neurol. 2010 Aug; 67(8):996-1001. PMID: 20697051.

Citations:
Kompoliti K, Stebbins GT, Goetz CG, Fan W. Association between antipsychotics and body mass index when treating patients with tics. J Child Adolesc Psychopharmacol. 2010 Aug; 20(4):277-81. PMID: 20807065.

Citations:
Colosimo C, Mart?nez-Mart?n P, Fabbrini G, Hauser RA, Merello M, Miyasaki J, Poewe W, Sampaio C, Rascol O, Stebbins GT, Schrag A, Goetz CG. Task force report on scales to assess dyskinesia in Parkinson's disease: critique and recommendations. Mov Disord. 2010 Jul 15; 25(9):1131-42. PMID: 20310033.

Citations:
Goetz CG, Stebbins GT, Chmura TA, Fahn S, Poewe W, Tanner CM. Teaching program for the Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale: (MDS-UPDRS). Mov Disord. 2010 Jul 15; 25(9):1190-4. PMID: 20629138.

Citations:
Goetz CG. Shaking up the Salpetriere: Jean-Martin Charcot and mercury-induced tremor. Neurology. 2010 May 25; 74(21):1739-42. PMID: 20498442.

Citations:
Obeso JA, Rodriguez-Oroz MC, Goetz CG, Marin C, Kordower JH, Rodriguez M, Hirsch EC, Farrer M, Schapira AH, Halliday G. Missing pieces in the Parkinson's disease puzzle. Nat Med. 2010 Jun; 16(6):653-61. PMID: 20495568.

Citations:
Friedman JH, Alves G, Hagell P, Marinus J, Marsh L, Martinez-Martin P, Goetz CG, Poewe W, Rascol O, Sampaio C, Stebbins G, Schrag A. Fatigue rating scales critique and recommendations by the Movement Disorders Society task force on rating scales for Parkinson's disease. Mov Disord. 2010 May 15; 25(7):805-22. PMID: 20461797.

Citations:
Goetz CG. New developments in depression, anxiety, compulsiveness, and hallucinations in Parkinson's disease. Mov Disord. 2010; 25 Suppl 1:S104-9. PMID: 20187250.

Citations:
Goetz CG. Chapter 15: Jean-Martin Charcot and the anatomo-clinical method of neurology. Handb Clin Neurol. 2010; 95:203-12. PMID: 19892118.

Citations:
Goetz CG. Scales to evaluate psychosis in Parkinson's disease. Parkinsonism Relat Disord. 2009 Dec; 15 Suppl 3:S38-41. PMID: 20083004.

Citations:
Goetz CG. [Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS): a new scale for the evaluation of Parkinson's disease]. Rev Neurol (Paris). 2010 Jan; 166(1):1-4. PMID: 19910010.

Citations:
Ravina B, Tanner C, Dieuliis D, Eberly S, Flagg E, Galpern WR, Fahn S, Goetz CG, Grate S, Kurlan R, Lang AE, Marek K, Kieburtz K, Oakes D, Elliott R, Shoulson I. A longitudinal program for biomarker development in Parkinson's disease: a feasibility study. Mov Disord. 2009 Oct 30; 24(14):2081-90. PMID: 19691116.

Citations:
Garcia-Arocena D, Yang JE, Brouwer JR, Tassone F, Iwahashi C, Berry-Kravis EM, Goetz CG, Sumis AM, Zhou L, Nguyen DV, Campos L, Howell E, Ludwig A, Greco C, Willemsen R, Hagerman RJ, Hagerman PJ. Fibroblast phenotype in male carriers of FMR1 premutation alleles. Hum Mol Genet. 2010 Jan 15; 19(2):299-312. PMID: 19864489.

Citations:
Goetz CG, Harter DH. Charcot and Pasteur: intersecting orbits in fin de si?cle French medicine. J Hist Neurosci. 2009 Oct; 18(4):378-86. PMID: 20183219.

Citations:
Huang P, Goetz CG, Woolson RF, Tilley B, Kerr D, Palesch Y, Elm J, Ravina B, Bergmann KJ, Kieburtz K. Using global statistical tests in long-term Parkinson's disease clinical trials. Mov Disord. 2009 Sep 15; 24(12):1732-9. PMID: 19514076.

Citations:
Goetz CG. Jean-Martin Charcot and his vibratory chair for Parkinson disease. Neurology. 2009 Aug 11; 73(6):475-8. PMID: 19667323.

Citations:
Goetz CG, Nutt JG, Stebbins GT, Chmura TA. Teaching program for the Unified Dyskinesia Rating Scale. Mov Disord. 2009 Jul 15; 24(9):1296-8. PMID: 19425060.

Citations:
Hinson VK, Goetz CG, Leurgans S, Fan W, Nguyen T, Hsu A. Reducing dosing frequency of carbidopa/levodopa: double-blind crossover study comparing twice-daily bilayer formulation of carbidopa/levodopa (IPX054) versus 4 daily doses of standard carbidopa/levodopa in stable Parkinson disease patients. Clin Neuropharmacol. 2009 Jul-Aug; 32(4):189-92. PMID: 19620848.

Citations:
Diederich NJ, F?nelon G, Stebbins G, Goetz CG. Hallucinations in Parkinson disease. Nat Rev Neurol. 2009 Jun; 5(6):331-42. PMID: 19498436.

Citations:
Bernard BA, Stebbins GT, Siegel S, Schultz TM, Hays C, Morrissey MJ, Leurgans S, Goetz CG. Determinants of quality of life in children with Gilles de la Tourette syndrome. Mov Disord. 2009 May 15; 24(7):1070-3. PMID: 19306279.

Citations:
Barton B, Zauber SE, Goetz CG. Movement disorders caused by medical disease. Semin Neurol. 2009 Apr; 29(2):97-110. PMID: 19370491.

Citations:
Evatt ML, Chaudhuri KR, Chou KL, Cubo E, Hinson V, Kompoliti K, Yang C, Poewe W, Rascol O, Sampaio C, Stebbins GT, Goetz CG. Dysautonomia rating scales in Parkinson's disease: sialorrhea, dysphagia, and constipation--critique and recommendations by movement disorders task force on rating scales for Parkinson's disease. Mov Disord. 2009 Apr 15; 24(5):635-46. PMID: 19205066.

Citations:
Goetz CG, Stebbins GT, Wolff D, DeLeeuw W, Bronte-Stewart H, Elble R, Hallett M, Nutt J, Ramig L, Sanger T, Wu AD, Kraus PH, Blasucci LM, Shamim EA, Sethi KD, Spielman J, Kubota K, Grove AS, Dishman E, Taylor CB. Testing objective measures of motor impairment in early Parkinson's disease: Feasibility study of an at-home testing device. Mov Disord. 2009 Mar 15; 24(4):551-6. PMID: 19086085.

Citations:
Olanow CW, Gracies JM, Goetz CG, Stoessl AJ, Freeman T, Kordower JH, Godbold J, Obeso JA. Clinical pattern and risk factors for dyskinesias following fetal nigral transplantation in Parkinson's disease: a double blind video-based analysis. Mov Disord. 2009 Feb 15; 24(3):336-43. PMID: 19006186.

Citations:
Cubo E, Chmura T, Goetz CG. Comparison of tic characteristics between children and adults. Mov Disord. 2008 Dec 15; 23(16):2407-11. PMID: 18855922.

Citations:
Goetz CG, Nutt JG, Stebbins GT. The Unified Dyskinesia Rating Scale: presentation and clinimetric profile. Mov Disord. 2008 Dec 15; 23(16):2398-403. PMID: 19025759.

Citations:
Goetz CG, Emre M, Dubois B. Parkinson's disease dementia: definitions, guidelines, and research perspectives in diagnosis. Ann Neurol. 2008 Dec; 64 Suppl 2:S81-92. PMID: 19127578.

Citations:
Goldman JG, Goetz CG, Brandabur M, Sanfilippo M, Stebbins GT. Effects of dopaminergic medications on psychosis and motor function in dementia with Lewy bodies. Mov Disord. 2008 Nov 15; 23(15):2248-50. PMID: 18823039.

Citations:
Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P, Poewe W, Sampaio C, Stern MB, Dodel R, Dubois B, Holloway R, Jankovic J, Kulisevsky J, Lang AE, Lees A, Leurgans S, LeWitt PA, Nyenhuis D, Olanow CW, Rascol O, Schrag A, Teresi JA, van Hilten JJ, LaPelle N. Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord. 2008 Nov 15; 23(15):2129-70. PMID: 19025984.

Citations:
Leentjens AF, Dujardin K, Marsh L, Martinez-Martin P, Richard IH, Starkstein SE, Weintraub D, Sampaio C, Poewe W, Rascol O, Stebbins GT, Goetz CG. Anxiety rating scales in Parkinson's disease: critique and recommendations. Mov Disord. 2008 Oct 30; 23(14):2015-25. PMID: 18792121.

Citations:
Leentjens AF, Dujardin K, Marsh L, Martinez-Martin P, Richard IH, Starkstein SE, Weintraub D, Sampaio C, Poewe W, Rascol O, Stebbins GT, Goetz CG. Apathy and anhedonia rating scales in Parkinson's disease: critique and recommendations. Mov Disord. 2008 Oct 30; 23(14):2004-14. PMID: 18709683.

Citations:
Louis ED, Broussolle E, Goetz CG, Krack P, Kaufmann P, Mazzoni P. Historical underpinnings of the term essential tremor in the late 19th century. Neurology. 2008 Sep 09; 71(11):856-9. PMID: 18779514.

Citations:
Diederich NJ, Goetz CG. The placebo treatments in neurosciences: New insights from clinical and neuroimaging studies. Neurology. 2008 Aug 26; 71(9):677-84. PMID: 18725593.

Citations:
Goetz CG, Fan W, Leurgans S. Antipsychotic medication treatment for mild hallucinations in Parkinson's disease: Positive impact on long-term worsening. Mov Disord. 2008 Aug 15; 23(11):1541-5. PMID: 18567004.

Citations:
Goetz CG, Leurgans S, Hinson VK, Blasucci LM, Zimmerman J, Fan W, Nguyen T, Hsu A. Evaluating Parkinson's disease patients at home: utility of self-videotaping for objective motor, dyskinesia, and ON-OFF assessments. Mov Disord. 2008 Jul 30; 23(10):1479-82. PMID: 18512751.

Citations:
Diederich NJ, Leurgans S, Fan W, Chmura TA, Goetz CG. Visual hallucinations and symptoms of REM sleep behavior disorder in Parkinsonian tauopathies. Int J Geriatr Psychiatry. 2008 Jun; 23(6):598-603. PMID: 18023069.

Citations:
Goetz CG, Wuu J, McDermott MP, Adler CH, Fahn S, Freed CR, Hauser RA, Olanow WC, Shoulson I, Tandon PK, Leurgans S. Placebo response in Parkinson's disease: comparisons among 11 trials covering medical and surgical interventions. Mov Disord. 2008 Apr 15; 23(5):690-9. PMID: 18228568.

Citations:
Goetz CG, Laska E, Hicking C, Damier P, M?ller T, Nutt J, Warren Olanow C, Rascol O, Russ H. Placebo influences on dyskinesia in Parkinson's disease. Mov Disord. 2008 Apr 15; 23(5):700-7. PMID: 18175337.

Citations:
Schwarzschild MA, Schwid SR, Marek K, Watts A, Lang AE, Oakes D, Shoulson I, Ascherio A, Hyson C, Gorbold E, Rudolph A, Kieburtz K, Fahn S, Gauger L, Goetz C, Seibyl J, Forrest M, Ondrasik J. Serum urate as a predictor of clinical and radiographic progression in Parkinson disease. Arch Neurol. 2008 Jun; 65(6):716-23. PMID: 18413464.

Citations:
Fernandez HH, Aarsland D, F?nelon G, Friedman JH, Marsh L, Tr?ster AI, Poewe W, Rascol O, Sampaio C, Stebbins GT, Goetz CG. Scales to assess psychosis in Parkinson's disease: Critique and recommendations. Mov Disord. 2008 Mar 15; 23(4):484-500. PMID: 18175343.

Citations:
Goetz CG. Concerning about the accuracy of data reported. Mov Disord. 2008 Mar 15; 23(4):473; author reply 473. PMID: 18383134.

Citations:
Leehey MA, Berry-Kravis E, Goetz CG, Zhang L, Hall DA, Li L, Rice CD, Lara R, Cogswell J, Reynolds A, Gane L, Jacquemont S, Tassone F, Grigsby J, Hagerman RJ, Hagerman PJ. FMR1 CGG repeat length predicts motor dysfunction in premutation carriers. Neurology. 2008 Apr 15; 70(16 Pt 2):1397-402. PMID: 18057320.

Citations:
Dubois B, Burn D, Goetz C, Aarsland D, Brown RG, Broe GA, Dickson D, Duyckaerts C, Cummings J, Gauthier S, Korczyn A, Lees A, Levy R, Litvan I, Mizuno Y, McKeith IG, Olanow CW, Poewe W, Sampaio C, Tolosa E, Emre M. Diagnostic procedures for Parkinson's disease dementia: recommendations from the movement disorder society task force. Mov Disord. 2007 Dec; 22(16):2314-24. PMID: 18098298.

Citations:
Goetz CG, Deuschl G. Disclosure on author work effort. Mov Disord. 2007 Oct 31; 22(14):1989. PMID: 17969060.

Citations:
Emre M, Aarsland D, Brown R, Burn DJ, Duyckaerts C, Mizuno Y, Broe GA, Cummings J, Dickson DW, Gauthier S, Goldman J, Goetz C, Korczyn A, Lees A, Levy R, Litvan I, McKeith I, Olanow W, Poewe W, Quinn N, Sampaio C, Tolosa E, Dubois B. Clinical diagnostic criteria for dementia associated with Parkinson's disease. Mov Disord. 2007 Sep 15; 22(12):1689-707; quiz 1837. PMID: 17542011.

Citations:
Fabbrini G, Brotchie JM, Grandas F, Nomoto M, Goetz CG. Levodopa-induced dyskinesias. Mov Disord. 2007 Jul 30; 22(10):1379-1389. PMID: 17427940.

Citations:
Goetz CG. J.-M. Charcot and simulated neurologic disease: attitudes and diagnostic strategies. Neurology. 2007 Jul 03; 69(1):103-9. PMID: 17606887.

Citations:
Schrag A, Barone P, Brown RG, Leentjens AF, McDonald WM, Starkstein S, Weintraub D, Poewe W, Rascol O, Sampaio C, Stebbins GT, Goetz CG. Depression rating scales in Parkinson's disease: critique and recommendations. Mov Disord. 2007 Jun 15; 22(8):1077-92. PMID: 17394234.

Citations:
Ravina B, Marder K, Fernandez HH, Friedman JH, McDonald W, Murphy D, Aarsland D, Babcock D, Cummings J, Endicott J, Factor S, Galpern W, Lees A, Marsh L, Stacy M, Gwinn-Hardy K, Voon V, Goetz C. Diagnostic criteria for psychosis in Parkinson's disease: report of an NINDS, NIMH work group. Mov Disord. 2007 Jun 15; 22(8):1061-8. PMID: 17266092.

Citations:
Broussolle E, Krack P, Thobois S, Xie-Brustolin J, Pollak P, Goetz CG. Contribution of Jules Froment to the study of parkinsonian rigidity. Mov Disord. 2007 May 15; 22(7):909-14. PMID: 17443696.

Citations:
Litvan I, Chesselet MF, Gasser T, Di Monte DA, Parker D, Hagg T, Hardy J, Jenner P, Myers RH, Price D, Hallett M, Langston WJ, Lang AE, Halliday G, Rocca W, Duyckaerts C, Dickson DW, Ben-Shlomo Y, Goetz CG, Melamed E. The etiopathogenesis of Parkinson disease and suggestions for future research. Part II. J Neuropathol Exp Neurol. 2007 May; 66(5):329-36. PMID: 17483689.

Citations:
Litvan I, Halliday G, Hallett M, Goetz CG, Rocca W, Duyckaerts C, Ben-Shlomo Y, Dickson DW, Lang AE, Chesselet MF, Langston WJ, Di Monte DA, Gasser T, Hagg T, Hardy J, Jenner P, Melamed E, Myers RH, Parker D, Price DL. The etiopathogenesis of Parkinson disease and suggestions for future research. Part I. J Neuropathol Exp Neurol. 2007 Apr; 66(4):251-7. PMID: 17413315.

Citations:
Goetz CG, Deuschl G. Author responsibilities and compliance with data source agreements. Mov Disord. 2007 Mar 15; 22(4):449. PMID: 17390388.

Citations:
Lippa CF, Duda JE, Grossman M, Hurtig HI, Aarsland D, Boeve BF, Brooks DJ, Dickson DW, Dubois B, Emre M, Fahn S, Farmer JM, Galasko D, Galvin JE, Goetz CG, Growdon JH, Gwinn-Hardy KA, Hardy J, Heutink P, Iwatsubo T, Kosaka K, Lee VM, Leverenz JB, Masliah E, McKeith IG, Nussbaum RL, Olanow CW, Ravina BM, Singleton AB, Tanner CM, Trojanowski JQ, Wszolek ZK. DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers. Neurology. 2007 Mar 13; 68(11):812-9. PMID: 17353469.

Citations:
Jasinska-Myga B, Opala G, Goetz CG, Tustanowski J, Ochudlo S, Gorzkowska A, Tyrpa J. Apolipoprotein E gene polymorphism, total plasma cholesterol level, and Parkinson disease dementia. Arch Neurol. 2007 Feb; 64(2):261-5. PMID: 17296843.

Citations:
Goetz CG, Damier P, Hicking C, Laska E, M?ller T, Olanow CW, Rascol O, Russ H. Sarizotan as a treatment for dyskinesias in Parkinson's disease: a double-blind placebo-controlled trial. Mov Disord. 2007 Jan 15; 22(2):179-86. PMID: 17094088.

Citations:
Goetz CG, Fahn S, Martinez-Martin P, Poewe W, Sampaio C, Stebbins GT, Stern MB, Tilley BC, Dodel R, Dubois B, Holloway R, Jankovic J, Kulisevsky J, Lang AE, Lees A, Leurgans S, LeWitt PA, Nyenhuis D, Olanow CW, Rascol O, Schrag A, Teresi JA, Van Hilten JJ, LaPelle N. Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Process, format, and clinimetric testing plan. Mov Disord. 2007 Jan; 22(1):41-7. PMID: 17115387.

Citations:
Berry-Kravis E, Goetz CG, Leehey MA, Hagerman RJ, Zhang L, Li L, Nguyen D, Hall DA, Tartaglia N, Cogswell J, Tassone F, Hagerman PJ. Neuropathic features in fragile X premutation carriers. Am J Med Genet A. 2007 Jan 01; 143A(1):19-26. PMID: 17152065.

Citations:
Goldman JG, Goetz CG. History of Parkinson's disease. Handb Clin Neurol. 2007; 83:107-28. PMID: 18808912.

Citations:
Friedman JH, Berman RM, Goetz CG, Factor SA, Ondo WG, Wojcieszek J, Carson WH, Marcus RN. Open-label flexible-dose pilot study to evaluate the safety and tolerability of aripiprazole in patients with psychosis associated with Parkinson's disease. Mov Disord. 2006 Dec; 21(12):2078-81. PMID: 17013906.

Citations:
Goetz CG, Vilensky JA. Early cinematographic studies of generalized dystonia. Mov Disord. 2006 Oct; 21(10):1561-5. PMID: 16830311.

Citations:
Elmer L, Schwid S, Eberly S, Goetz C, Fahn S, Kieburtz K, Oakes D, Blindauer K, Salzman P, Oren S, Prisco UL, Stern M, Shoulson I. Rasagiline-associated motor improvement in PD occurs without worsening of cognitive and behavioral symptoms. J Neurol Sci. 2006 Oct 25; 248(1-2):78-83. PMID: 16828804.

Citations:
Kroonenberg PM, Oort FJ, Stebbins GT, Leurgans SE, Cubo E, Goetz CG. Motor function in Parkinson's disease and supranuclear palsy: simultaneous factor analysis of a clinical scale in several populations. BMC Med Res Methodol. 2006 Jun 13; 6:26. PMID: 16772027.

Citations:
Goetz CG, Li JM, Wuu J, Leurgans S. Does seasonal variation affect hallucinations in PD? A longitudinal study. Mov Disord. 2006 Jun; 21(6):863-5. PMID: 16538649.

Citations:
Goetz CG, Schwid SR, Eberly SW, Oakes D, Shoulson I. Safety of rasagiline in elderly patients with Parkinson disease. Neurology. 2006 May 09; 66(9):1427-9. PMID: 16682679.

Citations:
Goetz CG, Fan W, Leurgans S, Bernard B, Stebbins GT. The malignant course of "benign hallucinations" in Parkinson disease. Arch Neurol. 2006 May; 63(5):713-6. PMID: 16682540.

Citations:
Goetz CG. Charcot in contemporary literature. J Hist Neurosci. 2006 Mar; 15(1):22-30. PMID: 16443570.

Citations:
Kompoliti K, Goetz CG, Morrissey M, Leurgans S. Gilles de la Tourette syndrome: patient's knowledge and concern of adverse effects. Mov Disord. 2006 Feb; 21(2):248-52. PMID: 16161137.

Citations:
Goetz CG, Wuu J, Curgian L, Leurgans S. Age-related influences on the clinical characteristics of new-onset hallucinations in Parkinson's disease patients. Mov Disord. 2006 Feb; 21(2):267-70. PMID: 16161144.

Citations:
Blindauer K, Shoulson I, Oakes D, Kieburtz K, Schwid S, Fahn S, Stern M, Goetz C, Nutt J, Goren S, Sayag N, Scolnik M, Levy R, Eyal E, Salzman P, Pagano M. A randomized controlled trial of etilevodopa in patients with Parkinson disease who have motor fluctuations. Arch Neurol. 2006 Feb; 63(2):210-6. PMID: 16476809.

Citations:
F?nelon G, Goetz CG, Karenberg A. Hallucinations in Parkinson disease in the prelevodopa era. Neurology. 2006 Jan 10; 66(1):93-8. PMID: 16401853.

Citations:
Vilensky JA, Goetz CG, Gilman S. Movement disorders associated with encephalitis lethargica: a video compilation. Mov Disord. 2006 Jan; 21(1):1-8. PMID: 16200538.

Citations:
Goetz CG. What's new? Clinical progression and staging of Parkinson's disease. J Neural Transm Suppl. 2006; (70):305-8. PMID: 17017545.

Citations:
Hinson VK, Weinstein S, Bernard B, Leurgans SE, Goetz CG. Single-blind clinical trial of psychotherapy for treatment of psychogenic movement disorders. Parkinsonism Relat Disord. 2006 Apr; 12(3):177-80. PMID: 16364676.

Citations:
Hinson VK, Cubo E, Comella CL, Goetz CG, Leurgans S. Rating scale for psychogenic movement disorders: scale development and clinimetric testing. Mov Disord. 2005 Dec; 20(12):1592-7. PMID: 16108025.

Citations:
McKeith IG, Dickson DW, Lowe J, Emre M, O'Brien JT, Feldman H, Cummings J, Duda JE, Lippa C, Perry EK, Aarsland D, Arai H, Ballard CG, Boeve B, Burn DJ, Costa D, Del Ser T, Dubois B, Galasko D, Gauthier S, Goetz CG, Gomez-Tortosa E, Halliday G, Hansen LA, Hardy J, Iwatsubo T, Kalaria RN, Kaufer D, Kenny RA, Korczyn A, Kosaka K, Lee VM, Lees A, Litvan I, Londos E, Lopez OL, Minoshima S, Mizuno Y, Molina JA, Mukaetova-Ladinska EB, Pasquier F, Perry RH, Schulz JB, Trojanowski JQ, Yamada M. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology. 2005 Dec 27; 65(12):1863-72. PMID: 16237129.

Citations:
Cubo E, Hinson VK, Goetz CG, Garcia Ruiz P, Garcia de Yebenes J, Marti MJ, Rodriguez Oroz MC, Linazasoro G, Chac?n J, V?zquez A, L?pez del Val J, Leurgans S, Wuu J. Transcultural comparison of psychogenic movement disorders. Mov Disord. 2005 Oct; 20(10):1343-5. PMID: 16001406.

Citations:
Goetz C, Foertsch D, Schoenberger J, Uhl E. Thermography - a valuable tool to test hydrocephalus shunt patency. Acta Neurochir (Wien). 2005 Nov; 147(11):1167-72; discussion 1172-3. PMID: 16133774.

Citations:
Schmid I, Stachel D, Graubner UB, Elsner R, Schulze S, P?llinger B, Goetz C, Haas RJ. [Supratentorial primitive neuroectodermal tumor: a single center experience and comparison with the literature]. Klin Padiatr. 2005 May-Jun; 217(3):153-7. PMID: 15858707.

Citations:
Goetz CG, Poewe W, Rascol O, Sampaio C. Evidence-based medical review update: pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004. Mov Disord. 2005 May; 20(5):523-39. PMID: 15818599.

Citations:
Elm JJ, Goetz CG, Ravina B, Shannon K, Wooten GF, Tanner CM, Palesch YY, Huang P, Guimaraes P, Kamp C, Tilley BC, Kieburtz K. A responsive outcome for Parkinson's disease neuroprotection futility studies. Ann Neurol. 2005 Feb; 57(2):197-203. PMID: 15668964.

Citations:
Diederich NJ, Goetz CG, Stebbins GT. Repeated visual hallucinations in Parkinson's disease as disturbed external/internal perceptions: focused review and a new integrative model. Mov Disord. 2005 Feb; 20(2):130-40. PMID: 15486924.

Citations:
Goetz CG, Wuu J, Curgian LM, Leurgans S. Hallucinations and sleep disorders in PD: six-year prospective longitudinal study. Neurology. 2005 Jan 11; 64(1):81-6. PMID: 15642908.

Citations:
Goetz CG. Movement disorders: understanding clinical trials. Lancet Neurol. 2005 Jan; 4(1):5-6. PMID: 15620847.

Citations:
Guimaraes P, Kieburtz K, Goetz CG, Elm JJ, Palesch YY, Huang P, Ravina B, Tanner CM, Tilley BC. Non-linearity of Parkinson's disease progression: implications for sample size calculations in clinical trials. Clin Trials. 2005; 2(6):509-18. PMID: 16422311.

Citations:
Berry-Kravis E, Potanos K, Weinberg D, Zhou L, Goetz CG. Fragile X-associated tremor/ataxia syndrome in sisters related to X-inactivation. Ann Neurol. 2005 Jan; 57(1):144-7. PMID: 15622531.

Citations:
Cubo E, Leurgans S, Goetz CG. Short-term and practice effects of metronome pacing in Parkinson's disease patients with gait freezing while in the 'on' state: randomized single blind evaluation. Parkinsonism Relat Disord. 2004 Dec; 10(8):507-10. PMID: 15542012.

Citations:
Goetz CG, Stebbins GT. Assuring interrater reliability for the UPDRS motor section: utility of the UPDRS teaching tape. Mov Disord. 2004 Dec; 19(12):1453-6. PMID: 15389981.

Citations:
Stebbins GT, Goetz CG, Carrillo MC, Bangen KJ, Turner DA, Glover GH, Gabrieli JD. Altered cortical visual processing in PD with hallucinations: an fMRI study. Neurology. 2004 Oct 26; 63(8):1409-16. PMID: 15505157.

Citations:
Goetz CG, Poewe W, Rascol O, Sampaio C, Stebbins GT, Counsell C, Giladi N, Holloway RG, Moore CG, Wenning GK, Yahr MD, Seidl L. Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations. Mov Disord. 2004 Sep; 19(9):1020-8. PMID: 15372591.

Citations:
Goldman JG, Goetz CG, Berry-Kravis E, Leurgans S, Zhou L. Genetic polymorphisms in Parkinson disease subjects with and without hallucinations: an analysis of the cholecystokinin system. Arch Neurol. 2004 Aug; 61(8):1280-4. PMID: 15313848.

Citations:
Li YJ, Hauser MA, Scott WK, Martin ER, Booze MW, Qin XJ, Walter JW, Nance MA, Hubble JP, Koller WC, Pahwa R, Stern MB, Hiner BC, Jankovic J, Goetz CG, Small GW, Mastaglia F, Haines JL, Pericak-Vance MA, Vance JM. Apolipoprotein E controls the risk and age at onset of Parkinson disease. Neurology. 2004 Jun 08; 62(11):2005-9. PMID: 15184605.

Citations:
Barboi AC, Goetz CG, Musetoiu R. The origins of scientific cinematography and early medical applications. Neurology. 2004 Jun 08; 62(11):2082-6. PMID: 15184618.

Citations:
Goetz CG. Medical-legal issues in Charcot's neurologic career. Neurology. 2004 May 25; 62(10):1827-33. PMID: 15159486.

Citations:
Goetz C. Re: UPDRS: Status and recommendations. Mov Disord. 2004 May; 19(5):605. PMID: 15133834.

Citations:
Olanow CW, Damier P, Goetz CG, Mueller T, Nutt J, Rascol O, Serbanescu A, Deckers F, Russ H. Multicenter, open-label, trial of sarizotan in Parkinson disease patients with levodopa-induced dyskinesias (the SPLENDID Study). Clin Neuropharmacol. 2004 Mar-Apr; 27(2):58-62. PMID: 15252265.

Citations:
Goetz CG, LeWitt PA, Weidenman M. Standardized training tools for the UPDRS activities of daily living scale: newly available teaching program. Mov Disord. 2003 Dec; 18(12):1455-8. PMID: 14673881.

Citations:
Li YJ, Oliveira SA, Xu P, Martin ER, Stenger JE, Scherzer CR, Hauser MA, Scott WK, Small GW, Nance MA, Watts RL, Hubble JP, Koller WC, Pahwa R, Stern MB, Hiner BC, Jankovic J, Goetz CG, Mastaglia F, Middleton LT, Roses AD, Saunders AM, Schmechel DE, Gullans SR, Haines JL, Gilbert JR, Vance JM, Pericak-Vance MA, Hulette C, Welsh-Bohmer KA. Glutathione S-transferase omega-1 modifies age-at-onset of Alzheimer disease and Parkinson disease. Hum Mol Genet. 2003 Dec 15; 12(24):3259-67. PMID: 14570706.

Citations:
Pappert EJ, Goetz CG, Louis ED, Blasucci L, Leurgans S. Objective assessments of longitudinal outcome in Gilles de la Tourette's syndrome. Neurology. 2003 Oct 14; 61(7):936-40. PMID: 14557563.

Citations:
Goetz CG, Janko K, Blasucci L, Jaglin JA. Impact of placebo assignment in clinical trials of Parkinson's disease. Mov Disord. 2003 Oct; 18(10):1146-9. PMID: 14534918.

Citations:
Cubo E, Moore CG, Leurgans S, Goetz CG. Wheeled and standard walkers in Parkinson's disease patients with gait freezing. Parkinsonism Relat Disord. 2003 Oct; 10(1):9-14. PMID: 14499200.

Citations:
Olanow CW, Goetz CG, Kordower JH, Stoessl AJ, Sossi V, Brin MF, Shannon KM, Nauert GM, Perl DP, Godbold J, Freeman TB. A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease. Ann Neurol. 2003 Sep; 54(3):403-14. PMID: 12953276.

Citations:
Diederich NJ, Pieri V, Goetz CG. Coping strategies for visual hallucinations in Parkinson's disease. Mov Disord. 2003 Jul; 18(7):831-2. PMID: 12815665.

Citations:
Hinson VK, Goetz CG. Torsion Dystonia in Children. Curr Treat Options Neurol. 2003 Jul; 5(4):291-297. PMID: 12791196.

Citations:
Oliveira SA, Scott WK, Nance MA, Watts RL, Hubble JP, Koller WC, Lyons KE, Pahwa R, Stern MB, Hiner BC, Jankovic J, Ondo WG, Allen FH, Scott BL, Goetz CG, Small GW, Mastaglia FL, Stajich JM, Zhang F, Booze MW, Reaves JA, Middleton LT, Haines JL, Pericak-Vance MA, Vance JM, Martin ER. Association study of Parkin gene polymorphisms with idiopathic Parkinson disease. Arch Neurol. 2003 Jul; 60(7):975-80. PMID: 12873854.

Citations:
Factor SA, Feustel PJ, Friedman JH, Comella CL, Goetz CG, Kurlan R, Parsa M, Pfeiffer R. Longitudinal outcome of Parkinson's disease patients with psychosis. Neurology. 2003 Jun 10; 60(11):1756-61. PMID: 12796526.

Citations:
Goetz CG. Pierre Marie: gifted intellect, poor timing and unchecked emotionality. J Hist Neurosci. 2003 Jun; 12(2):154-66. PMID: 12953618.

Citations:
Berry-Kravis E, Lewin F, Wuu J, Leehey M, Hagerman R, Hagerman P, Goetz CG. Tremor and ataxia in fragile X premutation carriers: blinded videotape study. Ann Neurol. 2003 May; 53(5):616-23. PMID: 12730995.

Citations:
Oliveira SA, Scott WK, Martin ER, Nance MA, Watts RL, Hubble JP, Koller WC, Pahwa R, Stern MB, Hiner BC, Ondo WG, Allen FH, Scott BL, Goetz CG, Small GW, Mastaglia F, Stajich JM, Zhang F, Booze MW, Winn MP, Middleton LT, Haines JL, Pericak-Vance MA, Vance JM. Parkin mutations and susceptibility alleles in late-onset Parkinson's disease. Ann Neurol. 2003 May; 53(5):624-9. PMID: 12730996.

Citations:
Goetz CG. [Progressive supranuclear palsy]. Rev Neurol (Paris). 2003 May; 159(5 Pt 2):3S25-9. PMID: 12773885.

Citations:
Litvan I, Bhatia KP, Burn DJ, Goetz CG, Lang AE, McKeith I, Quinn N, Sethi KD, Shults C, Wenning GK. Movement Disorders Society Scientific Issues Committee report: SIC Task Force appraisal of clinical diagnostic criteria for Parkinsonian disorders. Mov Disord. 2003 May; 18(5):467-86. PMID: 12722160.

Citations:
Goetz CG. The prefaces by Charcot: leitmotifs of an international career. Neurology. 2003 Apr 22; 60(8):1333-40. PMID: 12707438.

Citations:
van der Walt JM, Martin ER, Scott WK, Zhang F, Nance MA, Watts RL, Hubble JP, Haines JL, Koller WC, Lyons K, Pahwa R, Stern MB, Colcher A, Hiner BC, Jankovic J, Ondo WG, Allen FH, Goetz CG, Small GW, Mastaglia F, Roses AD, Stajich JM, Booze MW, Fujiwara K, Gibson RA, Middleton LT, Scott BL, Pericak-Vance MA, Vance JM. Genetic polymorphisms of the N-acetyltransferase genes and risk of Parkinson's disease. Neurology. 2003 Apr 08; 60(7):1189-91. PMID: 12682333.

Citations:
Diederich NJ, Moore CG, Leurgans SE, Chmura TA, Goetz CG. Parkinson disease with old-age onset: a comparative study with subjects with middle-age onset. Arch Neurol. 2003 Apr; 60(4):529-33. PMID: 12707066.

Citations:
Goetz CG, Leurgans S, Lang AE, Litvan I. Progression of gait, speech and swallowing deficits in progressive supranuclear palsy. Neurology. 2003 Mar 25; 60(6):917-22. PMID: 12654953.

Citations:
van der Walt JM, Nicodemus KK, Martin ER, Scott WK, Nance MA, Watts RL, Hubble JP, Haines JL, Koller WC, Lyons K, Pahwa R, Stern MB, Colcher A, Hiner BC, Jankovic J, Ondo WG, Allen FH, Goetz CG, Small GW, Mastaglia F, Stajich JM, McLaurin AC, Middleton LT, Scott BL, Schmechel DE, Pericak-Vance MA, Vance JM. Mitochondrial polymorphisms significantly reduce the risk of Parkinson disease. Am J Hum Genet. 2003 Apr; 72(4):804-11. PMID: 12618962.

Citations:
Goetz CG. Treatment of advanced Parkinson's disease: an evidence-based analysis. Adv Neurol. 2003; 91:213-28. PMID: 12442680.

Citations:
Goetz CG, Chmura TA, Lanska D. Part 1: the history of 19th century neurology and the American Neurological Association. Ann Neurol. 2003; 53 Suppl 4:S2-S26. PMID: 12722087.

Citations:
Goetz CG. History of the extensor plantar response: Babinski and Chaddock signs. Semin Neurol. 2002 Dec; 22(4):391-8. PMID: 12539060.

Citations:
Goetz CG. Jean-Martin Charcot and the aging brain. Arch Neurol. 2002 Nov; 59(11):1821-4. PMID: 12433272.

Citations:
Diederich NJ, Raman R, Leurgans S, Goetz CG. Progressive worsening of spatial and chromatic processing deficits in Parkinson disease. Arch Neurol. 2002 Aug; 59(8):1249-52. PMID: 12164720.

Citations:
Horn SS, Goetz CG. The election of Sarah McNutt as the first woman member of the American Neurological Association. Neurology. 2002 Jul 09; 59(1):113-7. PMID: 12105317.

Citations:
Kompoliti K, Adler CH, Raman R, Pincus JH, Leibowitz MT, Ferry JJ, Blasucci L, Caviness JN, Leurgans S, Chase WM, Yones LC, Tan E, Carvey P, Goetz CG. Gender and pramipexole effects on levodopa pharmacokinetics and pharmacodynamics. Neurology. 2002 May 14; 58(9):1418-22. PMID: 12011296.

Citations:
Rascol O, Goetz C, Koller W, Poewe W, Sampaio C. Treatment interventions for Parkinson's disease: an evidence based assessment. Lancet. 2002 May 04; 359(9317):1589-98. PMID: 12047983.

Citations:
Goetz CG, Hinson VK. Therapies for movement disorders. Arch Neurol. 2002 May; 59(5):699-702. PMID: 12020248.

Citations:
Pramstaller PP, K?nig G, Leenders K, Kann M, Hedrich K, Vieregge P, Goetz CG, Klein C. Parkin mutations in a patient with hemiparkinsonism-hemiatrophy: a clinical-genetic and PET study. Neurology. 2002 Mar 12; 58(5):808-10. PMID: 11889248.

Citations:
Li YJ, Scott WK, Hedges DJ, Zhang F, Gaskell PC, Nance MA, Watts RL, Hubble JP, Koller WC, Pahwa R, Stern MB, Hiner BC, Jankovic J, Allen FA, Goetz CG, Mastaglia F, Stajich JM, Gibson RA, Middleton LT, Saunders AM, Scott BL, Small GW, Nicodemus KK, Reed AD, Schmechel DE, Welsh-Bohmer KA, Conneally PM, Roses AD, Gilbert JR, Vance JM, Haines JL, Pericak-Vance MA. Age at onset in two common neurodegenerative diseases is genetically controlled. Am J Hum Genet. 2002 Apr; 70(4):985-93. PMID: 11875758.

Citations:
Goetz CG, Leurgans S, Raman R. Placebo-associated improvements in motor function: comparison of subjective and objective sections of the UPDRS in early Parkinson's disease. Mov Disord. 2002 Mar; 17(2):283-8. PMID: 11921113.

Citations:
Goetz CG, Carvey PM, Pappert EJ, Vu TQ, Leurgans SE. The role of the serotonin system in animal models of myoclonus. Adv Neurol. 2002; 89:244-8. PMID: 11968451.

Citations:
Goetz CG, Leurgans S, Pappert EJ, Raman R, Stemer AB. Prospective longitudinal assessment of hallucinations in Parkinson's disease. Neurology. 2001 Dec 11; 57(11):2078-82. PMID: 11739829.

Citations:
Goetz CG, Aminoff MJ. The Brown-S?quard and S. Weir Mitchell letters. Neurology. 2001 Dec 11; 57(11):2100-4. PMID: 11739833.

Citations:
Martin ER, Scott WK, Nance MA, Watts RL, Hubble JP, Koller WC, Lyons K, Pahwa R, Stern MB, Colcher A, Hiner BC, Jankovic J, Ondo WG, Allen FH, Goetz CG, Small GW, Masterman D, Mastaglia F, Laing NG, Stajich JM, Ribble RC, Booze MW, Rogala A, Hauser MA, Zhang F, Gibson RA, Middleton LT, Roses AD, Haines JL, Scott BL, Pericak-Vance MA, Vance JM. Association of single-nucleotide polymorphisms of the tau gene with late-onset Parkinson disease. JAMA. 2001 Nov 14; 286(18):2245-50. PMID: 11710889.

Citations:
Scott WK, Nance MA, Watts RL, Hubble JP, Koller WC, Lyons K, Pahwa R, Stern MB, Colcher A, Hiner BC, Jankovic J, Ondo WG, Allen FH, Goetz CG, Small GW, Masterman D, Mastaglia F, Laing NG, Stajich JM, Slotterbeck B, Booze MW, Ribble RC, Rampersaud E, West SG, Gibson RA, Middleton LT, Roses AD, Haines JL, Scott BL, Vance JM, Pericak-Vance MA. Complete genomic screen in Parkinson disease: evidence for multiple genes. JAMA. 2001 Nov 14; 286(18):2239-44. PMID: 11710888.

Citations:
Kompoliti K, Goetz CG, Leurgans S, Raman R, Comella CL. Estrogen, progesterone, and tic severity in women with Gilles de la Tourette syndrome. Neurology. 2001 Oct 23; 57(8):1519. PMID: 11673608.

Citations:
Goetz CG, Chmura TA, Lanska DJ. History of movement disorders as a neurological specialty: Part 14 of the MDS-sponsored History of Movement Disorders exhibit, Barcelona, June 2000. Mov Disord. 2001 Sep; 16(5):954-9. PMID: 11746630.

Citations:
Goetz CG, Chmura TA, Lanska DJ. Medical art and photography in the history of movement disorders: Part 13 of the MDS-sponsored History of Movement Disorders exhibit, Barcelona, June 2000. Mov Disord. 2001 Sep; 16(5):947-53. PMID: 11746629.

Citations:
Cubo E, Gracies JM, Benabou R, Olanow CW, Raman R, Leurgans S, Goetz CG. Early morning off-medication dyskinesias, dystonia, and choreic subtypes. Arch Neurol. 2001 Sep; 58(9):1379-82. PMID: 11559308.

Citations:
Goetz CG, Chmura TA, Lanska DJ. Seminal figures in the history of movement disorders: Gilles de la Tourette, Oppenheim, the Vogts, von Economo, Wilson, and Marsden. Part 12 of the MDS-sponsored History of Movement Disorders exhibit, Barcelona, June 2000. Mov Disord. 2001 Sep; 16(5):940-6. PMID: 11746628.

Citations:
Goetz CG. Poor Beard!! Charcot's internationalization of neurasthenia, the "American disease". Neurology. 2001 Aug 14; 57(3):510-4. PMID: 11502922.

Citations:
Kujawa KA, Niemi VR, Tomasi MA, Mayer NW, Cochran E, Goetz CG. Ballistic-choreic movements as the presenting feature of renal cancer. Arch Neurol. 2001 Jul; 58(7):1133-5. PMID: 11448303.

Citations:
Lanska DJ, Goetz CG, Chmura TA. Development of instruments for abnormal movements: dynamometers, the dynamograph, and tremor recorders. Part 9 of the MDS-Sponsored History of Movement Disorders Exhibit, Barcelona, June 2000. Mov Disord. 2001 Jul; 16(4):736-41. PMID: 11481701.

Citations:
Lanska DJ, Goetz CG, Chmura TA. Seminal figures in the History of Movement Disorders: Hammond, Osler, and Huntington. Part 11 of the MDS-Sponsored History of Movement Disorders Exhibit, Barcelona, June 2000. Mov Disord. 2001 Jul; 16(4):749-53. PMID: 11481703.

Citations:
Lanska DJ, Goetz CG, Chmura TA. Development of instruments for abnormal movements: postural sway and gait analyses. Part 10 of the MDS-Sponsored History of Movement Disorders Exhibit, Barcelona, June 2000. Mov Disord. 2001 Jul; 16(4):742-8. PMID: 11481702.

Citations:
Goetz CG, Leurgans S, Chmura TA. Home alone: methods to maximize tic expression for objective videotape assessments in Gilles de la Tourette syndrome. Mov Disord. 2001 Jul; 16(4):693-7. PMID: 11481693.

Citations:
Goetz CG, Chmura TA, Lanska DJ. Parkinsonism-plus syndromes: Part 7 of the MDS-sponsored History of Movement Disorders exhibit, Barcelona, June 2000. Mov Disord. 2001 May; 16(3):541. PMID: 11391756.

Citations:
Goetz CG, Chmura TA, Lanska DJ. History of Myoclonus: Part 8 of the MDS-sponsored History of Movement Disorders exhibit, Barcelona, June 2000. Mov Disord. 2001 May; 16(3):545-7. PMID: 11391757.

Citations:
Goetz CG, Chmura TA, Lanska DJ. Seminal figures in the history of movement disorders: Sydenham, Parkinson, and Charcot: Part 6 of the MDS-sponsored history of Movement Disorders exhibit, Barcelona, June 2000. Mov Disord. 2001 May; 16(3):537-40. PMID: 11391755.

Citations:
Goetz CG. [History of dystonia]. Rev Neurol (Paris). 2001 Apr; 157(4):446-9. PMID: 11398019.

Citations:
Goetz CG, Chmura TA, Lanska DJ. History of chorea: part 3 of the MDS-sponsored history of movement disorders exhibit, Barcelona, June 2000. Mov Disord. 2001 Mar; 16(2):331-8. PMID: 11295790.

Citations:
Goetz CG, Chmura TA, Lanska DJ. History of tic disorders and Gilles de la Tourette syndrome: part 5 of the MDS-sponsored history of movement disorders exhibit, Barcelona, June 2000. Mov Disord. 2001 Mar; 16(2):346-9. PMID: 11295792.

Citations:
Goetz CG, Chmura TA, Lanska DJ. History of dystonia: part 4 of the MDS-sponsored history of movement disorders exhibit, Barcelona, June, 2000. Mov Disord. 2001 Mar; 16(2):339-45. PMID: 11295791.

Citations:
Goetz CG, Horn SS. Treatment of tremor and dystonia. Neurol Clin. 2001 Feb; 19(1):129-44, vi-vii. PMID: 11471761.

Citations:
Rascol O, Nutt JG, Blin O, Goetz CG, Trugman JM, Soubrouillard C, Carter JH, Currie LJ, Fabre N, Thalamas C, Giardina WW, Wright S. Induction by dopamine D1 receptor agonist ABT-431 of dyskinesia similar to levodopa in patients with Parkinson disease. Arch Neurol. 2001 Feb; 58(2):249-54. PMID: 11176963.

Citations:
Goetz CG, Burke PF, Leurgans S, Berry-Kravis E, Blasucci LM, Raman R, Zhou L. Genetic variation analysis in parkinson disease patients with and without hallucinations: case-control study. Arch Neurol. 2001 Feb; 58(2):209-13. PMID: 11176958.

Citations:
Goetz CG, Chmura TA, Lanska DJ. The history of Parkinson's disease: part 2 of the MDS-sponsored History of Movement Disorders Exhibit, Barcelona, June, 2000. Mov Disord. 2001 Jan; 16(1):156-61. PMID: 11215579.

Citations:
Goetz CG, Kompoliti K. Rating scales and quantitative assessment of tics. Adv Neurol. 2001; 85:31-42. PMID: 11530438.

Citations:
Kompoliti K, Goetz CG, Vu TQ, Carvey PM, Leurgans S, Raman R. Estrogen supplementation in the posthypoxic myoclonus rat model. Clin Neuropharmacol. 2001 Jan-Feb; 24(1):58-61. PMID: 11290883.

Citations:
Goetz CG, Chmura TA, Lanska DJ. The basal ganglia: part 1 of the MDS-sponsored History of Movement Disorders Exhibit, Barcelona, June 2000. Mov Disord. 2001 Jan; 16(1):152-5. PMID: 11215578.

Citations:
Leckman JF, Cohen DJ, Goetz CG, Jankovic J. Tourette syndrome: pieces of the puzzle. Adv Neurol. 2001; 85:369-90. PMID: 11530445.

Citations:
Kompoliti K, Comella CL, Jaglin JA, Leurgans S, Raman R, Goetz CG. Menstrual-related changes in motoric function in women with Parkinson's disease. Neurology. 2000 Nov 28; 55(10):1572-5. PMID: 11094119.

Citations:
Lanska DJ, Goetz CG. Romberg's sign: development, adoption, and adaptation in the 19th century. Neurology. 2000 Oct 24; 55(8):1201-6. PMID: 11071500.

Citations:
Cubo E, Goetz CG. Dystonia secondary to Sj?gren-Larsson syndrome. Neurology. 2000 Oct 24; 55(8):1236-7. PMID: 11071513.

Citations:
Kujawa K, Leurgans S, Raman R, Blasucci L, Goetz CG. Acute orthostatic hypotension when starting dopamine agonists in Parkinson's disease. Arch Neurol. 2000 Oct; 57(10):1461-3. PMID: 11030798.

Citations:
Goetz CG, Blasucci LM, Leurgans S, Pappert EJ. Olanzapine and clozapine: comparative effects on motor function in hallucinating PD patients. Neurology. 2000 Sep 26; 55(6):789-94. PMID: 10993997.

Citations:
Diederich NJ, Alesch F, Goetz CG. Visual hallucinations induced by deep brain stimulation in Parkinson's disease. Clin Neuropharmacol. 2000 Sep-Oct; 23(5):287-9. PMID: 11154099.

Citations:
Goetz CG, Meisel E. Biological neurotoxins. Neurol Clin. 2000 Aug; 18(3):719-40. PMID: 10873240.

Citations:
Goetz CG. Battle of the titans: Charcot and Brown-S?quard on cerebral localization. Neurology. 2000 May 09; 54(9):1840-7. PMID: 10802795.

Citations:
Palfi S, Leventhal L, Goetz CG, Hantraye T, Roitberg BZ, Sramek J, Emborg M, Kordower JH. Delayed onset of progressive dystonia following subacute 3-nitropropionic acid treatment in Cebus apella monkeys. Mov Disord. 2000 May; 15(3):524-30. PMID: 10830419.

Citations:
Palfi S, Leventhal L, Goetz CG, Hantraye P, Roitberg BZ, Sramek J, Emborg M, Kordower JH. Delayed onset of progressive dystonia following subacute 3-nitropropionic acid treatment in Cebus apella monkeys. Mov Disord. 2000 May; 15(3):524-530. PMID: 28470737.

Citations:
Goetz CG, Stebbins GT, Blasucci LM. Differential progression of motor impairment in levodopa-treated Parkinson's disease. Mov Disord. 2000 May; 15(3):479-84. PMID: 10830412.

Citations:
Stebbins GT, Gabrieli JD, Shannon KM, Penn RD, Goetz CG. Impaired frontostriatal cognitive functioning following posteroventral pallidotomy in advanced Parkinson's disease. Brain Cogn. 2000 Apr; 42(3):348-63. PMID: 10753484.

Citations:
Goetz CG. William Osler: on Chorea: on Charcot. Ann Neurol. 2000 Mar; 47(3):404-7. PMID: 10716267.

Citations:
Sallee FR, Kurlan R, Goetz CG, Singer H, Scahill L, Law G, Dittman VM, Chappell PB. Ziprasidone treatment of children and adolescents with Tourette's syndrome: a pilot study. J Am Acad Child Adolesc Psychiatry. 2000 Mar; 39(3):292-9. PMID: 10714048.

Citations:
Diederich NJ, Goetz CG. Neuropsychological and behavioral aspects of transplants in Parkinson's disease and Huntington's disease. Brain Cogn. 2000 Mar; 42(2):294-306. PMID: 10744925.

Citations:
Diederich NJ, Pieri V, Goetz CG. [Visual hallucinations in Parkinson and Charles Bonnet Syndrome patients. A phenomenological and pathogenetic comparison]. Fortschr Neurol Psychiatr. 2000 Mar; 68(3):129-36. PMID: 10758844.

Citations:
Kompoliti K, Goetz CG, Leurgans S, Morrissey M, Siegel IM. "On" freezing in Parkinson's disease: resistance to visual cue walking devices. Mov Disord. 2000 Mar; 15(2):309-12. PMID: 10752582.

Citations:
Cubo E, Stebbins GT, Golbe LI, Nieves A, Leurgans S, Goetz CG, Kompoliti K. Application of the Unified Parkinson's Disease Rating Scale in progressive supranuclear palsy: factor analysis of the motor scale. Mov Disord. 2000 Mar; 15(2):276-9. PMID: 10752576.

Citations:
Goetz CG. Amyotrophic lateral sclerosis: early contributions of Jean-Martin Charcot. Muscle Nerve. 2000 Mar; 23(3):336-43. PMID: 10679709.

Citations:
Goetz CG, Leurgans S, Raman R, Stebbins GT. Objective changes in motor function during placebo treatment in PD. Neurology. 2000 Feb 08; 54(3):710-4. PMID: 10680808.

Citations:
Kompoliti K, Wang QE, Goetz CG, Leurgans S, Raman R. Effects of central dopaminergic stimulation by apomorphine on speech in Parkinson's disease. Neurology. 2000 Jan 25; 54(2):458-62. PMID: 10668714.

Citations:
Kompoliti K, Goetz CG. Therapeutic approaches. Adv Neurol. 2000; 82:217-21. PMID: 10624485.

Citations:
Pieri V, Diederich NJ, Raman R, Goetz CG. Decreased color discrimination and contrast sensitivity in Parkinson's disease. J Neurol Sci. 2000 Jan 01; 172(1):7-11. PMID: 10620653.

Citations:
Goetz CG. Nineteenth century studies of atypical parkinsonism: Charcot and his Salp?tri?re School. Adv Neurol. 2000; 82:1-8. PMID: 10624466.

Citations:
Goetz CG, Vu TQ, Carvey PM, Leurgans S. Posthypoxic myoclonus in the rat: natural history, stability, and serotonergic influences. Mov Disord. 2000; 15 Suppl 1:39-46. PMID: 10755271.

Citations:
Agid Y, Ahlskog E, Albanese A, Calne D, Chase T, De Yebenes J, Factor S, Fahn S, Gershanik O, Goetz C, Koller W, Kurth M, Lang A, Lees A, Lewitt P, Marsden D, Melamed E, Michel PP, Mizuno Y, Obeso J, Oertel W, Olanow W, Poewe W, Pollak P, Tolosa E, et al. Levodopa in the treatment of Parkinson's disease: a consensus meeting. Mov Disord. 1999 Nov; 14(6):911-3. PMID: 10584663.

Citations:
Kordower JH, Goetz CG. The first miracle in neurodegenerative disease: the discovery of oral levodopa. Brain Res Bull. 1999 Nov-Dec; 50(5-6):377-8. PMID: 10643443.

Citations:
Freeman TB, Vawter DE, Leaverton PE, Godbold JH, Hauser RA, Goetz CG, Olanow CW. Use of placebo surgery in controlled trials of a cellular-based therapy for Parkinson's disease. N Engl J Med. 1999 Sep 23; 341(13):988-92. PMID: 10498497.

Citations:
Scott WK, Yamaoka LH, Stajich JM, Scott BL, Vance JM, Roses AD, Pericak-Vance MA, Watts RL, Nance M, Hubble J, Koller W, Stern MB, Colcher A, Allen FH, Hiner BC, Jankovic J, Ondo W, Laing NG, Mastaglia F, Goetz C, Pappert E, Small GW, Masterman D, Haines JL, Davies TL. The alpha-synuclein gene is not a major risk factor in familial Parkinson disease. Neurogenetics. 1999 Sep; 2(3):191-2. PMID: 10541595.

Citations:
Kompoliti K, Goetz CG, Gajdusek DC, Cubo E. Movement disorders in Kuru. Mov Disord. 1999 Sep; 14(5):800-4. PMID: 10495041.

Citations:
Kordower JH, Palfi S, Chen EY, Ma SY, Sendera T, Cochran EJ, Cochran EJ, Mufson EJ, Penn R, Goetz CG, Comella CD. Clinicopathological findings following intraventricular glial-derived neurotrophic factor treatment in a patient with Parkinson's disease. Ann Neurol. 1999 Sep; 46(3):419-24. PMID: 10482276.

Citations:
Stebbins GT, Goetz CG, Lang AE, Cubo E. Factor analysis of the motor section of the unified Parkinson's disease rating scale during the off-state. Mov Disord. 1999 Jul; 14(4):585-9. PMID: 10435494.

Citations:
Barboi AC, Goetz CG. Parkinson's disease. Clin Neuropharmacol. 1999 Jul-Aug; 22(4):184-91. PMID: 10442246.

Citations:
Goetz CG. Charcot and the myth of misogyny. Neurology. 1999 May 12; 52(8):1678-86. PMID: 10331699.

Citations:
Goetz CG, Pappert EJ, Louis ED, Raman R, Leurgans S. Advantages of a modified scoring method for the Rush Video-Based Tic Rating Scale. Mov Disord. 1999 May; 14(3):502-6. PMID: 10348478.

Citations:
Goetz CG, Blasucci L, Stebbins GT. Switching dopamine agonists in advanced Parkinson's disease: is rapid titration preferable to slow? Neurology. 1999 Apr 12; 52(6):1227-9. PMID: 10214748.

Citations:
Stebbins GT, Gabrieli JD, Masciari F, Monti L, Goetz CG. Delayed recognition memory in Parkinson's disease: a role for working memory? Neuropsychologia. 1999 Apr; 37(4):503-10. PMID: 10215097.

Citations:
Pappert EJ, Goetz CG, Niederman FG, Raman R, Leurgans S. Hallucinations, sleep fragmentation, and altered dream phenomena in Parkinson's disease. Mov Disord. 1999 Jan; 14(1):117-21. PMID: 9918353.

Citations:
Goetz CG. Hallucinations in Parkinson's disease: the clinical syndrome. Adv Neurol. 1999; 80:419-23. PMID: 10410750.

Citations:
Bakdash T, Goetz CG, Singer HS, Cardoso F. A child with recurrent episodes of involuntary movements. Mov Disord. 1999 Jan; 14(1):146-54. PMID: 9918359.

Citations:
Goetz CG. Rating scales for dyskinesias in Parkinson's disease. Mov Disord. 1999; 14 Suppl 1:48-53. PMID: 10493403.

Citations:
Pappert EJ, Goetz CG, Vu TQ, Ling ZD, Leurgans S, Raman R, Carvey PM. Animal model of posthypoxic myoclonus: effects of serotonergic antagonists. Neurology. 1999 Jan 01; 52(1):16-21. PMID: 9921842.

Citations:
Diederich NJ, Goetz CG, Raman R, Pappert EJ, Leurgans S, Piery V. Poor visual discrimination and visual hallucinations in Parkinson's disease. Clin Neuropharmacol. 1998 Sep-Oct; 21(5):289-95. PMID: 9789709.

Citations:
Goetz CG, Vogel C, Tanner CM, Stebbins GT. Early dopaminergic drug-induced hallucinations in parkinsonian patients. Neurology. 1998 Sep; 51(3):811-4. PMID: 9748031.

Citations:
Kompoliti K, Goetz CG, Litvan I, Jellinger K, Verny M. Pharmacological therapy in progressive supranuclear palsy. Arch Neurol. 1998 Aug; 55(8):1099-102. PMID: 9708960.

Citations:
Kompoliti K, Goetz CG. Neuropharmacology in the elderly. Neurol Clin. 1998 Aug; 16(3):599-610. PMID: 9666039.

Citations:
Kompoliti K, Goetz CG, Boeve BF, Maraganore DM, Ahlskog JE, Marsden CD, Bhatia KP, Greene PE, Przedborski S, Seal EC, Burns RS, Hauser RA, Gauger LL, Factor SA, Molho ES, Riley DE. Clinical presentation and pharmacological therapy in corticobasal degeneration. Arch Neurol. 1998 Jul; 55(7):957-61. PMID: 9678313.

Citations:
Stebbins GT, Goetz CG. Factor structure of the Unified Parkinson's Disease Rating Scale: Motor Examination section. Mov Disord. 1998 Jul; 13(4):633-6. PMID: 9686766.

Citations:
Litvan I, MacIntyre A, Goetz CG, Wenning GK, Jellinger K, Verny M, Bartko JJ, Jankovic J, McKee A, Brandel JP, Chaudhuri KR, Lai EC, D'Olhaberriague L, Pearce RK, Agid Y. Accuracy of the clinical diagnoses of Lewy body disease, Parkinson disease, and dementia with Lewy bodies: a clinicopathologic study. Arch Neurol. 1998 Jul; 55(7):969-78. PMID: 9678315.

Citations:
Goetz CG. Influence of COMT inhibition on levodopa pharmacology and therapy. Neurology. 1998 May; 50(5 Suppl 5):S26-30. PMID: 9591519.

Citations:
Goetz CG. Highlights of the North American and European experiences. Neurology. 1998 May; 50(5 Suppl 5):S15-6. PMID: 9591517.

Citations:
Goetz CG. Georges Guillain's neurologic exploration of America. Neurology. 1998 May; 50(5):1451-5. PMID: 9596004.

Citations:
Goetz CG. New lessons from old drugs: amantadine and Parkinson's disease. Neurology. 1998 May; 50(5):1211-2. PMID: 9595964.

Citations:
Kompoliti K, Goetz CG. Hyperkinetic movement disorders misdiagnosed as tics in Gilles de la Tourette syndrome. Mov Disord. 1998 May; 13(3):477-80. PMID: 9613740.

Citations:
Buchman AS, Comella CL, Leurgans S, Stebbins GT, Goetz CG. The effect of changes in head posture on the patterns of muscle activity in cervical dystonia (CD). Mov Disord. 1998 May; 13(3):490-6. PMID: 9613743.

Citations:
Pappert EJ, Goetz CG, Stebbins GT, Belden M, Carvey PM. 5-Hydroxytryptophan-induced myoclonus in guinea pigs: mediation through 5-HT1/2 receptor subtypes. Eur J Pharmacol. 1998 Apr 17; 347(1):51-6. PMID: 9650847.

Citations:
Diederich NJ, Goetz CG. Drug-induced movement disorders. Neurol Clin. 1998 Feb; 16(1):125-39. PMID: 9421544.

Citations:
Goetz CG, Pappert EJ, Blasucci LM, Stebbins GT, Ling ZD, Nora MV, Carvey PM. Intravenous levodopa in hallucinating Parkinson's disease patients: high-dose challenge does not precipitate hallucinations. Neurology. 1998 Feb; 50(2):515-7. PMID: 9484386.

Citations:
Litvan I, Booth V, Wenning GK, Bartko JJ, Goetz CG, McKee A, Jankovic J, Jellinger K, Lai EC, Brandel JP, Verny M, Chaudhuri KR, Pearce RK, Agid Y. Retrospective application of a set of clinical diagnostic criteria for the diagnosis of multiple system atrophy. J Neural Transm (Vienna). 1998; 105(2-3):217-27. PMID: 9660099.

Citations:
Bennett DA, Shannon KM, Beckett LA, Goetz CG, Wilson RS. Metric properties of nurses' ratings of parkinsonian signs with a modified Unified Parkinson's Disease Rating Scale. Neurology. 1997 Dec; 49(6):1580-7. PMID: 9409350.

Citations:
Goetz CG. Eye signs and tic disorders: Gilles de la Tourette's syndrome. J Am Optom Assoc. 1997 Nov; 68(11):688-92. PMID: 9409103.

Citations:
Kompoliti K, Pappert EJ, Goetz CG, Ford B, Wood NW. Progressive cognitive decline with truncal/limb ataxia and ballistic movements. Mov Disord. 1997 Nov; 12(6):1075-84. PMID: 9399242.

Citations:
Goetz CG, Stebbins GT, Blasucci LM, Grobman MS. Efficacy of a patient-training videotape on motor fluctuations for on-off diaries in Parkinson's disease. Mov Disord. 1997 Nov; 12(6):1039-41. PMID: 9399233.

Citations:
Watts RL, Subramanian T, Freeman A, Goetz CG, Penn RD, Stebbins GT, Kordower JH, Bakay RA. Effect of stereotaxic intrastriatal cografts of autologous adrenal medulla and peripheral nerve in Parkinson's disease: two-year follow-up study. Exp Neurol. 1997 Oct; 147(2):510-7. PMID: 9344575.

Citations:
Litvan I, Goetz CG, Jankovic J, Wenning GK, Booth V, Bartko JJ, McKee A, Jellinger K, Lai EC, Brandel JP, Verny M, Chaudhuri KR, Pearce RK, Agid Y. What is the accuracy of the clinical diagnosis of multiple system atrophy? A clinicopathologic study. Arch Neurol. 1997 Aug; 54(8):937-44. PMID: 9267967.

Citations:
Pappert EJ, Lipton JW, Goetz CG, Ling ZD, Stebbins GT, Carvey PM. The stability of carbidopa in solution. Mov Disord. 1997 Jul; 12(4):608-10. PMID: 9251084.

Citations:
Comella CL, Stebbins GT, Goetz CG, Chmura TA, Bressman SB, Lang AE. Teaching tape for the motor section of the Toronto Western Spasmodic Torticollis Scale. Mov Disord. 1997 Jul; 12(4):570-5. PMID: 9251076.

Citations:
Litvan I, Agid Y, Sastry N, Jankovic J, Wenning GK, Goetz CG, Verny M, Brandel JP, Jellinger K, Chaudhuri KR, McKee A, Lai EC, Pearce RK, Bartko JJ, Sastrj N. What are the obstacles for an accurate clinical diagnosis of Pick's disease? A clinicopathologic study. Neurology. 1997 Jul; 49(1):62-9. PMID: 9222171.

Citations:
Kordower JH, Freeman TB, Bakay RA, Goetz CG, Olanow CW. Treatment with fetal allografts. Neurology. 1997 Jun; 48(6):1737-8. PMID: 9191805.

Citations:
Freeman TB, Vawter D, Goetz CG, Leaverton PE, Hauser RA, Sanberg PR, Godbold JH, Olanow CW. Toward the use of surgical placebo-controlled trials. Transplant Proc. 1997 Jun; 29(4):1925. PMID: 9193457.

Citations:
Kompoliti K, Goetz CG. Tourette syndrome. Clinical rating and quantitative assessment of tics. Neurol Clin. 1997 May; 15(2):239-54. PMID: 9106419.

Citations:
Goetz CG. Jean-Martin Charcot and Silas Weir Mitchell. Neurology. 1997 Apr; 48(4):1128-32. PMID: 9109917.

Citations:
Gabrieli JD, Stebbins GT, Singh J, Willingham DB, Goetz CG. Intact mirror-tracing and impaired rotary-pursuit skill learning in patients with Huntington's disease: evidence for dissociable memory systems in skill learning. Neuropsychology. 1997 Apr; 11(2):272-81. PMID: 9110333.

Citations:
Kordower JH, Goetz CG, Freeman TB, Olanow CW. Dopaminergic transplants in patients with Parkinson's disease: neuroanatomical correlates of clinical recovery. Exp Neurol. 1997 Mar; 144(1):41-6. PMID: 9126150.

Citations:
Goetz CG. New strategies with dopaminergic drugs: modified formulations of levodopa and novel agonists. Exp Neurol. 1997 Mar; 144(1):17-20. PMID: 9126145.

Citations:
Diederich NJ, Comella CL, Goetz CG. [Botulin toxin: principles of action and neurological indications]. Presse Med. 1997 Feb 01; 26(2):96-100. PMID: 9082423.

Citations:
Litvan I, Agid Y, Goetz C, Jankovic J, Wenning GK, Brandel JP, Lai EC, Verny M, Ray-Chaudhuri K, McKee A, Jellinger K, Pearce RK, Bartko JJ. Accuracy of the clinical diagnosis of corticobasal degeneration: a clinicopathologic study. Neurology. 1997 Jan; 48(1):119-25. PMID: 9008506.

Citations:
Pappert EJ, Goetz CG, Niederman F, Ling ZD, Stebbins GT, Carvey PM. Liquid levodopa/carbidopa produces significant improvement in motor function without dyskinesia exacerbation. Neurology. 1996 Dec; 47(6):1493-5. PMID: 8960733.

Citations:
Goetz CG. An early photographic case of probable progressive supranuclear palsy. Mov Disord. 1996 Nov; 11(6):617-8. PMID: 8914085.

Citations:
Pappert EJ, Tangney CC, Goetz CG, Ling ZD, Lipton JW, Stebbins GT, Carvey PM. Alpha-tocopherol in the ventricular cerebrospinal fluid of Parkinson's disease patients: dose-response study and correlations with plasma levels. Neurology. 1996 Oct; 47(4):1037-42. PMID: 8857741.

Citations:
Diederich N, Hilger C, Goetz CG, Keipes M, Hentges F, Vieregge P, Metz H. Genetic variability of the CYP 2D6 gene is not a risk factor for sporadic Parkinson's disease. Ann Neurol. 1996 Sep; 40(3):463-5. PMID: 8797539.

Citations:
Mady S, Wax P, Wang D, Goetz C, Hadley C, Love R. Pediatric clozapine intoxication. Am J Emerg Med. 1996 Sep; 14(5):462-3. PMID: 8765110.

Citations:
Bonduelle M, Goetz CG. Charcot and aphasia. J Hist Neurosci. 1996 Aug; 5(2):108-16. PMID: 11619038.

Citations:
Goetz CG, Pappert EJ. Early American professorships in neurology. Ann Neurol. 1996 Aug; 40(2):258-63. PMID: 8773612.

Citations:
Litvan I, Agid Y, Calne D, Campbell G, Dubois B, Duvoisin RC, Goetz CG, Golbe LI, Grafman J, Growdon JH, Hallett M, Jankovic J, Quinn NP, Tolosa E, Zee DS. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology. 1996 Jul; 47(1):1-9. PMID: 8710059.

Citations:
Fahn S, Brin MF, Dwork AJ, Weiner WJ, Goetz CG, Rajput AH. Case 1, 1996: rapidly progressive parkinsonism, incontinence, impotency, and levodopa-induced moaning in a patient with multiple myeloma. Mov Disord. 1996 May; 11(3):298-310. PMID: 8723148.

Citations:
Goetz CG, Diederich NJ. There is a renaissance of interest in pallidotomy for Parkinson's disease. Nat Med. 1996 May; 2(5):510-4. PMID: 8616702.

Citations:
Weissenborn K, R?ckert N, Ehrenheim C, Schellong S, Goetz C, Lubach D. Neuropsychological deficits in patients with Sneddon's syndrome. J Neurol. 1996 Apr; 243(4):357-63. PMID: 8965111.

Citations:
Litvan I, Agid Y, Jankovic J, Goetz C, Brandel JP, Lai EC, Wenning G, D'Olhaberriague L, Verny M, Chaudhuri KR, McKee A, Jellinger K, Bartko JJ, Mangone CA, Pearce RK. Accuracy of clinical criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome). Neurology. 1996 Apr; 46(4):922-30. PMID: 8780065.

Citations:
Bennett DA, Beckett LA, Murray AM, Shannon KM, Goetz CG, Pilgrim DM, Evans DA. Prevalence of parkinsonian signs and associated mortality in a community population of older people. N Engl J Med. 1996 Jan 11; 334(2):71-6. PMID: 8531961.

Citations:
Pappert EJ, Buhrfiend C, Lipton JW, Carvey PM, Stebbins GT, Goetz CG. Levodopa stability in solution: time course, environmental effects, and practical recommendations for clinical use. Mov Disord. 1996 Jan; 11(1):24-6. PMID: 8771063.

Citations:
Goetz CG, Bonduelle M. Charcot as therapeutic interventionist and treating neurologist. Neurology. 1995 Nov; 45(11):2102-6. PMID: 7501168.

Citations:
Hubble JP, Koller WC, Cutler NR, Sramek JJ, Friedman J, Goetz C, Ranhosky A, Korts D, Elvin A. Pramipexole in patients with early Parkinson's disease. Clin Neuropharmacol. 1995 Aug; 18(4):338-47. PMID: 8665547.

Citations:
Pappert EJ, Goetz CG. Early American neurologic textbooks. Neurology. 1995 Jun; 45(6):1228-32. PMID: 7783901.

Citations:
McDermott MP, Jankovic J, Carter J, Fahn S, Gauthier S, Goetz CG, Golbe LI, Koller W, Lang AE, Olanow CW, et al. Factors predictive of the need for levodopa therapy in early, untreated Parkinson's disease. The Parkinson Study Group. Arch Neurol. 1995 Jun; 52(6):565-70. PMID: 7763203.

Citations:
Goetz CG, Stebbins GT, Chmura TA, Fahn S, Klawans HL, Marsden CD. Teaching tape for the motor section of the unified Parkinson's disease rating scale. Mov Disord. 1995 May; 10(3):263-6. PMID: 7544438.

Citations:
Goetz CG, Stebbins GT. Mortality and hallucinations in nursing home patients with advanced Parkinson's disease. Neurology. 1995 Apr; 45(4):669-71. PMID: 7723953.

Citations:
Comella CL, Goetz CG. Akathisia in Parkinson's disease. Mov Disord. 1994 Sep; 9(5):545-9. PMID: 7990849.

Citations:
Goetz C. [Charcot: a scientific Janus]. Rev Neurol (Paris). 1994 Aug-Sep; 150(8-9):485-9. PMID: 7754281.

Citations:
Goetz CG, Stebbins GT, Shale HM, Lang AE, Chernik DA, Chmura TA, Ahlskog JE, Dorflinger EE. Utility of an objective dyskinesia rating scale for Parkinson's disease: inter- and intrarater reliability assessment. Mov Disord. 1994 Jul; 9(4):390-4. PMID: 7969204.

Citations:
Goetz CG, Bolla KI, Rogers SM. Neurologic health outcomes and Agent Orange: Institute of Medicine report. Neurology. 1994 May; 44(5):801-9. PMID: 8190278.

Citations:
Goetz CG, Stebbins GT, Thelen JA. Talipexole and adult Gilles de la Tourette's syndrome: double-blind, placebo-controlled clinical trial. Mov Disord. 1994 May; 9(3):315-7. PMID: 7913738.

Citations:
Comella CL, Stebbins GT, Brown-Toms N, Goetz CG. Physical therapy and Parkinson's disease: a controlled clinical trial. Neurology. 1994 Mar; 44(3 Pt 1):376-8. PMID: 8145901.

Citations:
Olanow CW, Marsden CD, Lang AE, Goetz CG. The role of surgery in Parkinson's disease management. Neurology. 1994 Mar; 44(3 Suppl 1):S17-20. PMID: 8121577.

Citations:
Goetz CG, Penn RD, Klawans HL. Fetal-tissue transplantation for Parkinson's disease. N Engl J Med. 1993 Nov 11; 329(20):1498; author reply 1499-500. PMID: 8413464.

Citations:
Goetz CG, Stebbins GT. Risk factors for nursing home placement in advanced Parkinson's disease. Neurology. 1993 Nov; 43(11):2227-9. PMID: 8232934.

Citations:
Kurth MC, Tetrud JW, Tanner CM, Irwin I, Stebbins GT, Goetz CG, Langston JW. Double-blind, placebo-controlled, crossover study of duodenal infusion of levodopa/carbidopa in Parkinson's disease patients with 'on-off' fluctuations. Neurology. 1993 Sep; 43(9):1698-703. PMID: 8414015.

Citations:
Samtleben W, Bauriedel G, Bosch T, Goetz C, Klare B, Gurland HJ. Renal complications of infected ventriculoatrial shunts. Artif Organs. 1993 Aug; 17(8):695-701. PMID: 8215950.

Citations:
Buchman AS, Comella CL, Stebbins GT, Tanner CM, Goetz CG. Quantitative electromyographic analysis of changes in muscle activity following botulinum toxin therapy for cervical dystonia. Clin Neuropharmacol. 1993 Jun; 16(3):205-10. PMID: 8504437.

Citations:
Goetz CG, Thelen JA, MacLeod CM, Carvey PM, Bartley EA, Stebbins GT. Blood levodopa levels and unified Parkinson's disease rating scale function: with and without exercise. Neurology. 1993 May; 43(5):1040-2. PMID: 8492923.

Citations:
Carvey PM, Ptak LR, Nath ST, Sierens DK, Mufson EJ, Goetz CG, Klawans HL. Striatal extracts from patients with Parkinson's disease promote dopamine neuron growth in mesencephalic cultures. Exp Neurol. 1993 Mar; 120(1):149-52. PMID: 8097475.

Citations:
Diederich NJ, Goetz CG. [Fetal and adrenal transplantation in Parkinson disease: theoretical bases and clinical results]. Bull Soc Sci Med Grand Duche Luxemb. 1993; 130(1):25-36. PMID: 8222013.

Citations:
Goetz CG, De Long MR, Penn RD, Bakay RA. Neurosurgical horizons in Parkinson's disease. Neurology. 1993 Jan; 43(1):1-7. PMID: 8423869.

Citations:
Wilson RS, Gilley DW, Tanner CM, Goetz CG. Ideational fluency in Parkinson's disease. Brain Cogn. 1992 Nov; 20(2):236-44. PMID: 1449756.

Citations:
Goetz CG, Pappert EJ. Trauma and movement disorders. Neurol Clin. 1992 Nov; 10(4):907-19. PMID: 1435664.

Citations:
Diederich N, Goetz CG, Stebbins GT, Klawans HL, Nittner K, Koulosakis A, Sanker P, Sturm V. Blinded evaluation confirms long-term asymmetric effect of unilateral thalamotomy or subthalamotomy on tremor in Parkinson's disease. Neurology. 1992 Jul; 42(7):1311-4. PMID: 1620340.

Citations:
Goetz CG, Diederich NJ. Dopaminergic agonists in the treatment of Parkinson's disease. Neurol Clin. 1992 May; 10(2):527-40. PMID: 1350052.

Citations:
Comella CL, Buchman AS, Tanner CM, Brown-Toms NC, Goetz CG. Botulinum toxin injection for spasmodic torticollis: increased magnitude of benefit with electromyographic assistance. Neurology. 1992 Apr; 42(4):878-82. PMID: 1565246.

Citations:
Goetz CG, Tanner CM, Stebbins GT, Leipzig G, Carr WC. Adult tics in Gilles de la Tourette's syndrome: description and risk factors. Neurology. 1992 Apr; 42(4):784-8. PMID: 1565232.

Citations:
Langston JW, Widner H, Goetz CG, Brooks D, Fahn S, Freeman T, Watts R. Core assessment program for intracerebral transplantations (CAPIT). Mov Disord. 1992; 7(1):2-13. PMID: 1557062.

Citations:
Goetz CG. Clonidine and clonazepam in Tourette syndrome. Adv Neurol. 1992; 58:245-51. PMID: 1414629.

Citations:
Goetz CG, Stebbins GT, Klawans HL, Koller WC, Grossman RG, Bakay RA, Penn RD. United Parkinson Foundation Neurotransplantation Registry on adrenal medullary transplants: presurgical, and 1- and 2-year follow-up. Neurology. 1991 Nov; 41(11):1719-22. PMID: 1944898.

Citations:
Carvey PM, Ptak LR, Lo ES, Lin DH, Buhrfiend CM, Goetz CG, Klawans HL. Levodopa reduces the growth promoting effects of striatal extracts on rostral mesencephalic tegmentum cultures. Exp Neurol. 1991 Oct; 114(1):28-34. PMID: 1915732.

Citations:
Koller WC, Block GA, Ahlskog JE, Ahrens S, Cedarbaum JM, Cyhan G, Goetz CG, LeWitt PA, Liss C, McLean L, et al. Effect of MK-458 (HPMC) in Parkinson's disease previously untreated with dopaminergic drugs. A double-blind, placebo-controlled multicenter study. Clin Neuropharmacol. 1991 Aug; 14(4):322-9. PMID: 1913699.

Citations:
Carvey PM, McRae A, Lint TF, Ptak LR, Lo ES, Goetz CG, Klawans HL. The potential use of a dopamine neuron antibody and a striatal-derived neurotrophic factor as diagnostic markers in Parkinson's disease. Neurology. 1991 May; 41(5 Suppl 2):53-8; discussion 59-60. PMID: 2041594.

Citations:
Kordower JH, Cochran E, Penn RD, Goetz CG. Putative chromaffin cell survival and enhanced host-derived TH-fiber innervation following a functional adrenal medulla autograft for Parkinson's disease. Ann Neurol. 1991 Apr; 29(4):405-12. PMID: 1681779.

Citations:
Goetz CG. Visual art in the neurologic career of Jean-Martin Charcot. Arch Neurol. 1991 Apr; 48(4):421-5. PMID: 2012518.

Citations:
Shults CW, O'Connor DT, Baird A, Hill R, Goetz CG, Watts RL, Klawans HL, Carvey PM, Bakay RA, Gage FH, et al. Clinical improvement in parkinsonian patients undergoing adrenal to caudate transplantation is not reflected by chromogranin A or basic fibroblast growth factor in ventricular fluid. Exp Neurol. 1991 Mar; 111(3):276-81. PMID: 1999231.

Citations:
Goetz CG, Stebbins GT. Effects of head trauma from motor vehicle accidents on Parkinson's disease. Ann Neurol. 1991 Feb; 29(2):191-3. PMID: 2012388.

Citations:
Olanow CW, Koller W, Goetz CG, Stebbins GT, Cahill DW, Gauger LL, Morantz R, Penn RD, Tanner CM, Klawans HL, et al. Autologous transplantation of adrenal medulla in Parkinson's disease. 18-month results. Arch Neurol. 1990 Dec; 47(12):1286-9. PMID: 2252446.

Citations:
Diederich N, Goetz CG, Comella CL. New approaches in the treatment of the dystonias. Klin Wochenschr. 1990 Oct 03; 68(19):935-41. PMID: 2232624.

Citations:
Jankovic J, McDermott M, Carter J, Gauthier S, Goetz C, Golbe L, Huber S, Koller W, Olanow C, Shoulson I, et al. Variable expression of Parkinson's disease: a base-line analysis of the DATATOP cohort. The Parkinson Study Group. Neurology. 1990 Oct; 40(10):1529-34. PMID: 2215943.

Citations:
Goetz CG. Dopaminergic agonists in the treatment of Parkinson's disease. Neurology. 1990 Oct; 40(10 Suppl 3):suppl 50-4; discussion 54-7. PMID: 1977104.

Citations:
Goetz CG, Tanner CM, Penn RD, Stebbins GT, Gilley DW, Shannon KM, Klawans HL, Comella CL, Wilson RS, Witt T. Adrenal medullary transplant to the striatum of patients with advanced Parkinson's disease: 1-year motor and psychomotor data. Neurology. 1990 Feb; 40(2):273-6. PMID: 2300248.

Citations:
Goetz CG, Stebbins GT, Klawans HL, Koller WC, Grossman RG, Bakay RA, Penn RD. United Parkinson Foundation Neurotransplantation Registry: multicenter US and Canadian data base, presurgical and 12 month follow-up. Prog Brain Res. 1990; 82:611-7. PMID: 2290962.

Citations:
Goetz CG, Tanner CM. Gilles de la Tourette's syndrome in twins: clinical and neurochemical data. Mov Disord. 1990; 5(2):173-5. PMID: 1691443.

Citations:
Dietz MA, Goetz CG, Stebbins GT. Evaluation of a modified inverted walking stick as a treatment for parkinsonian freezing episodes. Mov Disord. 1990; 5(3):243-7. PMID: 2388642.

Citations:
Carvey PM, McRae A, Ptak LR, Kao LC, Lo ES, Goetz CG, Tanner CM, Penn RD, Klawans HL. Disappearance of a putative DA-neuron antibody following adrenal medulla transplantation: relationship to a striatal-derived DA neuron trophic factor. Prog Brain Res. 1990; 82:693-7. PMID: 2290972.

Citations:
Goetz CG, Tanner CM, Gilley DW, Klawans HL. Development and progression of motor fluctuations and side effects in Parkinson's disease: comparison of Sinemet CR versus carbidopa/levodopa. Neurology. 1989 Nov; 39(11 Suppl 2):63-6; discussion 72-3. PMID: 2586764.

Citations:
Uitti RJ, Tanner CM, Rajput AH, Goetz CG, Klawans HL, Thiessen B. Hypersexuality with antiparkinsonian therapy. Clin Neuropharmacol. 1989 Oct; 12(5):375-83. PMID: 2575449.

Citations:
Fox JH, Bennett DA, Goetz CG, Penn RD, Savoy S, Clasen R, Wilson RS. Induction of parkinsonism by intraventricular bethanechol in a patient with Alzheimer's disease. Neurology. 1989 Sep; 39(9):1265. PMID: 2570380.

Citations:
Bennett DA, Ristanovic RK, Morrell F, Goetz CG. Dystonic posturing in temporal lobe seizures. Neurology. 1989 Sep; 39(9):1270-2. PMID: 2590310.

Citations:
Goetz CG, Shannon KM, Tanner CM, Carroll VS, Klawans HL. Agonist substitution in advanced Parkinson's disease. Neurology. 1989 Aug; 39(8):1121-2. PMID: 2761708.

Citations:
Tanner CM, Chen B, Wang W, Peng M, Liu Z, Liang X, Kao LC, Gilley DW, Goetz CG, Schoenberg BS. Environmental factors and Parkinson's disease: a case-control study in China. Neurology. 1989 May; 39(5):660-4. PMID: 2710356.

Citations:
Goetz CG. [Where are the grafts in Parkinson's disease?]. Rev Prat. 1989 Mar 09; 39(8):675-7. PMID: 2727574.

Citations:
Goetz CG, Olanow CW, Koller WC, Penn RD, Cahill D, Morantz R, Stebbins G, Tanner CM, Klawans HL, Shannon KM. Multicenter study of autologous adrenal medullary transplantation to the corpus striatum in patients with advanced Parkinson's disease. N Engl J Med. 1989 Feb 09; 320(6):337-41. PMID: 2643770.

Citations:
Goetz CG, Tanner CM, Stebbins GT, Buchman AS. Risk factors for progression in Parkinson's disease. Neurology. 1988 Dec; 38(12):1841-4. PMID: 3194061.

Citations:
McRae-Degueurce A, Klawans HL, Penn RD, Dahlstrom A, Tanner CM, Goetz CG, Carvey PM. An antibody in the CSF of Parkinson's disease patients disappears following adrenal medulla transplantation. Neurosci Lett. 1988 Nov 22; 94(1-2):192-7. PMID: 3241668.

Citations:
Sprague SM, Corwin HL, Tanner CM, Wilson RS, Green BJ, Goetz CG. Relationship of aluminum to neurocognitive dysfunction in chronic dialysis patients. Arch Intern Med. 1988 Oct; 148(10):2169-72. PMID: 3178374.

Citations:
Goetz CG. Shakespeare in Charcot's neurologic teaching. Arch Neurol. 1988 Aug; 45(8):920-1. PMID: 3293556.

Citations:
Goetz CG, Tanner CM, Shannon KM, Carroll VS, Klawans HL, Carvey PM, Gilley D. Controlled-release carbidopa/levodopa (CR4-Sinemet) in Parkinson's disease patients with and without motor fluctuations. Neurology. 1988 Jul; 38(7):1143-6. PMID: 3290706.

Citations:
Penn RD, Goetz CG, Tanner CM, Klawans HL, Shannon KM, Comella CL, Witt TR. The adrenal medullary transplant operation for Parkinson's disease: clinical observations in five patients. Neurosurgery. 1988 Jun; 22(6 Pt 1):999-1004. PMID: 3419583.

Citations:
Buchman AS, Goetz CG, Klawans HL. Hemiparkinsonism with hemiatrophy. Neurology. 1988 Apr; 38(4):527-30. PMID: 3352904.

Citations:
Goetz CG. The Salp?tri?re in the wake of Charcot's death. Arch Neurol. 1988 Apr; 45(4):444-7. PMID: 3281638.

Citations:
Klawans HL, Tanner CM, Goetz CG. Epidemiology and pathophysiology of tardive dyskinesias. Adv Neurol. 1988; 49:185-97. PMID: 2894124.

Citations:
Goetz CG, Penn RD, Tanner CM. Efficacy of cervical cord stimulation in dystonia. Adv Neurol. 1988; 50:645-9. PMID: 3261120.

Citations:
Tanner CM, Wilson RS, Goetz CG, Shannon KM. The predictive value of acute antimuscarinic drugs for the chronic efficacy of antimuscarinic drugs in adults with focal dystonia. Adv Neurol. 1988; 50:557-60. PMID: 3400510.

Citations:
Carvey PM, Hitri A, Goetz CG, Tanner CM, Klawans HL. Concurrent treatment with benztropine and haloperidol attenuates development of behavioral hypersensitivity but not dopamine receptor proliferation. Life Sci. 1988; 42(22):2207-15. PMID: 3374255.

Citations:
Jankovic J, Armstrong D, Low NL, Goetz CG. Case 2, 1988. Congenital mental retardation and juvenile parkinsonism. Mov Disord. 1988; 3(4):352-61. PMID: 3211183.

Citations:
Shannon KM, Goetz CG, Carroll VS, Tanner CM, Klawans HL. Amantadine and motor fluctuations in chronic Parkinson's disease. Clin Neuropharmacol. 1987 Dec; 10(6):522-6. PMID: 3427558.

Citations:
Goetz CG, Tanner CM, Wilson RS, Shannon KM. A rating scale for Gilles de la Tourette's syndrome: description, reliability, and validity data. Neurology. 1987 Sep; 37(9):1542-4. PMID: 3476860.

Citations:
Goetz CG, Tanner CM, Carroll VS, Shannon KM, Klawans HL. Controlled-release Sinemet. Neurology. 1987 Sep; 37(9):1567-8. PMID: 3627466.

Citations:
Goetz CG. Charcot at the Salp?tri?re: ambulatory automatisms. Neurology. 1987 Jun; 37(6):1084-8. PMID: 3295588.

Citations:
Buchman AS, Bennett DA, Goetz CG. Bromocriptine-induced myoclonus. Neurology. 1987 May; 37(5):885. PMID: 3574698.

Citations:
Goetz CG, Tanner CM, Klawans HL, Shannon KM, Carroll VS. Parkinson's disease and motor fluctuations: long-acting carbidopa/levodopa (CR-4-Sinemet). Neurology. 1987 May; 37(5):875-8. PMID: 3574696.

Citations:
Goetz CG, Tanner CM, Shannon KM. Progression of Parkinson's disease without levodopa. Neurology. 1987 Apr; 37(4):695-8. PMID: 3561783.

Citations:
Goetz CG, Tanner CM, Wilson RS, Carroll VS, Como PG, Shannon KM. Clonidine and Gilles de la Tourette's syndrome: double-blind study using objective rating methods. Ann Neurol. 1987 Mar; 21(3):307-10. PMID: 3300518.

Citations:
Tanner CM, Goetz CG, Glantz RH, Klawans HL. Pergolide mesylate: four years experience in Parkinson's disease. Adv Neurol. 1987; 45:547-9. PMID: 3825732.

Citations:
Goetz CG, Shannon KM, Carroll VS, Tanner CM, Weingarten R. The autonomic nervous system in Gilles de la Tourette's syndrome. Mov Disord. 1987; 2(2):99-102. PMID: 2904121.

Citations:
Goetz CG, Wilson RS, Tanner CM, Garron DC. Relationships among pain, depression, and sleep alterations in Parkinson's disease. Adv Neurol. 1987; 45:345-7. PMID: 3825708.

Citations:
Klawans HL, Carvey PM, Nelson D, Tanner CM, Goetz CG. The effect of thioridazine on haloperidol induced behavioral hypersensitivity. Life Sci. 1986 May 12; 38(19):1707-14. PMID: 3702600.

Citations:
Carvey PM, Kao LC, Tanner CM, Goetz CG, Klawans HL. The effect of antimuscarinic agents on haloperidol induced behavioral hypersensitivity. Eur J Pharmacol. 1986 Jan 21; 120(2):193-9. PMID: 3948919.

Citations:
Goetz CG, Tanner CM, Levy M, Wilson RS, Garron DC. Pain in Parkinson's disease. Mov Disord. 1986; 1(1):45-9. PMID: 3504231.

Citations:
Carvey P, Paulseth JE, Goetz CG, Klawans HL. L-5-HTP-induced myoclonic jumping behavior in guinea pigs: an update. Adv Neurol. 1986; 43:509-17. PMID: 3484857.

Citations:
Goetz CG, Lutge W, Tanner CM. Autonomic dysfunction in Parkinson's disease. Neurology. 1986 Jan; 36(1):73-5. PMID: 3941786.

Citations:
Goetz CG. Charcot on Parkinson's disease. Mov Disord. 1986; 1(1):27-32. PMID: 3332804.

Citations:
Klawans HL, Carvey PM, Tanner CM, Goetz CG. Drug-induced myoclonus. Adv Neurol. 1986; 43:251-64. PMID: 3484854.

Citations:
Tanner CM, Chhablani R, Goetz CG, Klawans HL. Pergolide mesylate: lack of cardiac toxicity in patients with cardiac disease. Neurology. 1985 Jun; 35(6):918-21. PMID: 3889707.

Citations:
Goetz CG, Tanner CM, Glantz RH, Klawans HL. Chronic agonist therapy for Parkinson's disease: a 5-year study of bromocriptine and pergolide. Neurology. 1985 May; 35(5):749-51. PMID: 3990974.

Citations:
Klawans HL, Carvey P, Tanner CM, Goetz CG. The pathophysiology of tardive dyskinesia. J Clin Psychiatry. 1985 Apr; 46(4 Pt 2):38-41. PMID: 2858479.

Citations:
Goetz CG, Tanner CM, Klawans HL. Bupropion in Parkinson's disease. Neurology. 1984 Aug; 34(8):1092-4. PMID: 6431314.

Citations:
Goetz CG, Carvey PM, Tanner CM, Klawans HL. Neuroleptic-induced dopamine hyposensitivity. Life Sci. 1984 Apr 09; 34(15):1475-9. PMID: 6538629.

Citations:
Goetz CG, Tanner CM, Klawans HL. Fluphenazine and multifocal tic disorders. Arch Neurol. 1984 Mar; 41(3):271-2. PMID: 6582810.

Citations:
Gerratt BR, Goetz CG, Fisher HB. Speech abnormalities in tardive dyskinesia. Arch Neurol. 1984 Mar; 41(3):273-6. PMID: 6696646.

Citations:
Goetz CG. Sinemet skin rash. Clin Neuropharmacol. 1984; 7(1):107-8. PMID: 6231101.

Citations:
Goetz CG, Tanner CM, Klawans HL. The pharmacology of olivopontocerebellar atrophy. Adv Neurol. 1984; 41:143-8. PMID: 6496225.

Citations:
Goetz CG. Skin rash associated with Sinemet 25/100. N Engl J Med. 1983 Dec 01; 309(22):1387-8. PMID: 6226874.

Citations:
Goetz CG, Tanner CM, Glantz R, Klawans HL. Pergolide in Parkinson's disease. Arch Neurol. 1983 Dec; 40(13):785-7. PMID: 6639407.

Citations:
Goetz CG, Klawans HL. On the mechanism of sudden death in Moersch-Woltman syndrome. Neurology. 1983 Jul; 33(7):930-2. PMID: 6683379.

Citations:
Klawans HL, Goetz CG, Carvey P. Animal models of tardive dyskinesias. Clin Neuropharmacol. 1983 Jun; 6(2):129-35. PMID: 6133617.

Citations:
Goetz CG. Drug-induced Parkinsonism and idiopathic Parkinson's disease. Arch Neurol. 1983 May; 40(5):325-6. PMID: 6133514.

Citations:
Klawans HL, Tanner CM, Glatt S, Goetz CG. A 6-month trial of pergolide mesylate in the treatment of idiopathic Parkinson's disease. Adv Neurol. 1983; 37:75-83. PMID: 6344592.

Citations:
Klawans HL, Goetz CG, Tanner CM, Nausieda PA, Weiner WJ. Levodopa-free periods ("drug holidays") in the management of parkinsonism. Adv Neurol. 1983; 37:33-43. PMID: 6858778.

Citations:
Goetz CG, Klawans HL, Carvey P. Animal models of tardive dyskinesia: their use in the search for new treatment methods. Mod Probl Pharmacopsychiatry. 1983; 21:5-20. PMID: 6140633.

Citations:
Goetz CG, Tanner CM, Klawans HL. Drug holiday in the management of Parkinson disease. Clin Neuropharmacol. 1982 Dec; 5(4):351-64. PMID: 6760963.

Citations:
Tanner CM, Goetz CG, Klawans HL. Cholinergic mechanisms in Tourette syndrome. Neurology. 1982 Nov; 32(11):1315-7. PMID: 6957735.

Citations:
Tanner CM, Goetz CG, Glantz RH, Glatt SL, Klawans HL. Pergolide mesylate and idiopathic Parkinson disease. Neurology. 1982 Oct; 32(10):1175-9. PMID: 6889702.

Citations:
Klawans HL, Stein RW, Tanner CM, Goetz CG. A pure parkinsonian syndrome following acute carbon monoxide intoxication. Arch Neurol. 1982 May; 39(5):302-4. PMID: 7073551.

Citations:
Glantz R, Weiner WJ, Goetz CG, Nausieda PA, Klawans HL. Drug-induced asterixis in Parkinson disease. Neurology. 1982 May; 32(5):553-5. PMID: 7200212.

Citations:
Goetz CG, Tanner CM, Klawans HL. Pharmacology of hallucinations induced by long-term drug therapy. Am J Psychiatry. 1982 Apr; 139(4):494-7. PMID: 6802003.

Citations:
Klawans HL, Glantz R, Tanner CM, Goetz CG. Primary writing tremor: a selective action tremor. Neurology. 1982 Feb; 32(2):203-6. PMID: 7198747.

Citations:
Goetz CG, Klawans HL. Gilles de la Tourette on Tourette syndrome. Adv Neurol. 1982; 35:1-16. PMID: 6756085.

Citations:
Weiner WJ, Carvey P, Nausieda PA, Goetz CG, Klawans HL. Effect of chronic levodopa on haloperidol-induced behavioral supersensitivity in the guinea pig. Adv Neurol. 1982; 35:213-9. PMID: 6890754.

Citations:
Goetz CG, Tanner CM, Klawans HL. Compressive neuropathies in Tourette syndrome. Adv Neurol. 1982; 35:345-7. PMID: 6959511.

Citations:
Goetz CG, Tanner CM, Nausieda PA. Weekly drug holiday in Parkinson disease. Neurology. 1981 Nov; 31(11):1460-2. PMID: 7031503.

Citations:
Goetz CG, Klawans HL. Drug-induced extrapyramidal disorders - a neuropsychiatric interface. J Clin Psychopharmacol. 1981 Sep; 1(5):297-303. PMID: 6120959.

Citations:
Tanner CM, Goetz CG. CPK values in Parkinson's disease. N Engl J Med. 1981 Jun 25; 304(26):1608-9. PMID: 7231513.

Citations:
Weiner WJ, Carvey P, Nausieda PA, Goetz CG, Klawans HL. The effect of chronic levodopa on haloperidol induced behavioral supersensitivity in the guinea pig. Life Sci. 1981 May 11; 28(19):2173-8. PMID: 7195969.

Citations:
Goetz CG, Nausieda PA, Weiner WJ, Klawans HL. Practical guidelines for drug holidays in parkinsonian patients. Neurology. 1981 May; 31(5):641-2. PMID: 7194987.

Citations:
Koller WC, Weiner WJ, Perlik S, Nausieda PA, Goetz CG, Klawans HL. Complications of chronic levodopa therapy: long-term efficacy of drug holiday. Neurology. 1981 Apr; 31(4):473-6. PMID: 7194441.

Citations:
Glantz R, Goetz CG, Nausieda PA, Weiner WJ, Klawans HL. The effect of bromocriptine (BCT) on the on-off phenomenon. J Neural Transm. 1981; 52(1-2):41-7. PMID: 7026735.

Citations:
Tanner C, Goetz CG, Weiner WJ. Anticholinergics and tardive dyskinesia. Am J Psychiatry. 1980 Nov; 137(11):1470-1. PMID: 6108080.

Citations:
Goetz CG, Klawans HL. Gilles de la Tourette syndrome and compressive neuropathies. Ann Neurol. 1980 Oct; 8(4):453. PMID: 6933884.

Citations:
Klawans HL, Goetz CG, Perlik S. Presymptomatic and early detection in Huntington's disease. Ann Neurol. 1980 Oct; 8(4):343-7. PMID: 6449173.

Citations:
Klawans HL, Goetz CG, Perlik S. Tardive dyskinesia: review and update. Am J Psychiatry. 1980 Aug; 137(8):900-8. PMID: 6106395.

Citations:
Goetz CG, Klawans HL. Chronic agonist-induced hypersensitivity and on-off hyperkinesis. Ann Neurol. 1979 Sep; 6(3):277-8. PMID: 534431.

Citations:
Weiner WJ, Goetz CG, Nausieda PA, Klawans HL. Amphetamine-induced hypersensitivity in guinea pigs. Neurology. 1979 Jul; 29(7):1054-7. PMID: 572936.

Citations:
Klawans HL, Goetz CG, Volkman P, Nausieda PA, Weiner WJ. Lergotrile in the treatment of parkinsonism. Neurology. 1978 Jul; 28(7):699-702. PMID: 566868.

Citations:
Weiner WJ, Goetz CG, Nausieda PA, Klawans HL. Respiratory dyskinesias: extrapyramidal dysfunction and dyspnea. Ann Intern Med. 1978 Mar; 88(3):327-31. PMID: 629494.

Citations:
Weiner WJ, Goetz C, Nausleda PA, Klawans HL. Clonazepam and dopamine-related stereotyped behavior. Life Sci. 1977 Oct 01; 21(7):901-6. PMID: 562960.

Citations:
Klawans HL, Goetz C, Nausieda PA, Weiner WJ. Levodopa-induced dopamine receptor hypersensitivity. Trans Am Neurol Assoc. 1977; 102:80-3. PMID: 616121.

Citations:
Klawans HL, Goetz C, Nausieda PA, Weiner WJ. Recent advances in the biochemical pharmacology of extrapyramidal movement disorders. Adv Exp Med Biol. 1977; 90:21-47. PMID: 145167.

Citations:
Klawans HL, Goetz C, Bergen D. Levodopa-induced myoclonus. Arch Neurol. 1975 May; 32(5):330-4. PMID: 1079721.

Citations:
Klawans HL, Goetz C, Weiner WJ. Dopamine receptor site sensitivity in hyperthyroid and hypothyroid guinea pigs. Adv Neurol. 1974; 5:495-500. PMID: 4474797.

Citations:
Klawans HL, Goetz C, Weiner WJ. 5-Hydroxytryptophan-induced myoclonus in guinea pigs and the possible role of serotonin in infantile myoclonus. Neurology. 1973 Nov; 23(11):1234-40. PMID: 4147723.

Citations:

Year	Publications
1994	7
1995	6
1996	14
1997	18
1998	17
1999	17
2000	25
2001	30
2002	11
2003	22
2004	10
2005	13
2006	14
2007	18
2008	17
2009	15
2010	12
2011	16
2012	8
2013	18
2014	17
2015	10
2016	16
2017	15
2018	15
2019	7
2020	16
2021	14
2022	19
2023	12

Goetz's Networks

Click the

Explore

buttons for more information and interactive visualizations!

Concepts (1028)

Explore

Co-Authors (24)

Explore

Similar People (60)

Explore

Same Department

Explore